Abstract
Background
The pathogen Helicobacter pylori encounters many stressors as it transits to and infects the gastric epithelium. Gastric acidity is the predominate stressor encountered by the bacterium during initial infection and establishment of persistent infection. H. pylori initiates a rapid response to acid to maintain intracellular pH and proton motive force appropriate for a neutralophile. However, acid sensing by H. pylori may also serve as a transcriptional trigger to increase the levels of other pathogenic factors needed to subvert host defenses such as acid acclimation, antioxidants, flagellar synthesis and assembly, and CagA secretion.
Materials and Methods
H. pylori were acid-challenged at pH 3.0, 4.5, 6.0 vs non-acidic pH for four hours in the presence of urea, followed by RNAseq analysis and qPCR. Cytoplasmic pH was monitored under the same conditions.
Results
About 250 genes were induced and an equal number were repressed at acidic pHs. Genes encoding for antioxidant proteins, flagellar structural proteins, particularly class 2 genes, T4SS/CagPAI, FoF1-ATPase and proteins involved in acid acclimation were highly expressed at acidic pH. Cytoplasmic pH decreased from 7.8 at pHout of 8.0 to 6.0 at pHout of 3.0.
Conclusions
These results suggest that increasing extracellular or intracellular acidity or both are detected by the bacterium and serve as a signal to initiate increased production of protective and pathogenic factors needed to counter host defenses for persistent infection. These changes are dependent on degree of acidity and time of acid exposure, triggering a coordinated response to the environment required for colonization.
Introduction
H. pylori colonizes the normal acid-secreting stomach of about 50% of the world’s population, leading to gastritis, gastric and duodenal ulcers, gastric carcinoma, and MALT lymphoma (1–5). Persistent infection with H. pylori causes immune activation and increases the risk of developing gastric cancer about 20-fold (1). Initial infection often occurs early in life probably due to lower acid secretion {Agunod, 1969 #558} and typically evades clearance by the immune system (6). While bioenergetically a neutralophile, H. pylori is the only organism capable of colonizing the normal human stomach (7). As such, it is continually exposed to a variable range of acidity from pH 1.0 to pH 6.0 in the gastric environment (8).
Most neutralophillic bacteria have developed strategies to maintain cytoplasmic pH (pHin) between pH 7.5 and pH 8.0 over a range of external pH (pHout) between pH 4.0 and pH 8.0. The relatively constant pHin is due mainly to a proton barrier afforded by the inner membrane and internal buffering by cytoplasmic proteins. These passive acid resistance mechanisms can maintain a constant pHin when exposed to moderate acidity (pH 4.0–7.0) but not to the pHs encountered in the gastric environment (pH 1.0 to pH 6.0) (9).
In addition to the passive acid responses, neutralophilic bacteria respond to mild acidity via the acid tolerance response (ATR). ATR is the concept that prior exposure to mild acidity prepares bacteria for exposure to high acidity through a series of mechanisms involving transcriptional and translational responses. These mechanisms include the export of protons by amino acid decarboxylation coupled to amino acid/base counter-transport, by oxidases and by the FOF1-ATPase, the generation of NH3 by amino acid deiminases, deaminases and urease, decreasing proton permeability of the cell envelope and protection and repair of acid damaged proteins, purines and pyrimidines.
The H. pylori acid transcriptome has been analyzed in at least 4 microarray studies (10–13). Unfortunately, there is very little agreement in gene expression levels among the various transcriptome analyses. The lack of reproducibility is likely due to differences in the experimental design and array technology (Table 1). Each study used a different strain of H. pylori (G-27, 26695, NTU-D1 and SS1). The media used differed among the four studies (BHI, Brucella broth, Columbia agar) and only one study included urea in the incubation medium (10). The level of acidity varied from 4.5 to 6.2 and the acid exposure time was 30 minutes to 48 hours. Different microarray platforms were used including fluorescent slide arrays and colorimetric and radiolabeled microarray membranes.
Table 1.
Comparison of experimental conditions of acid transcriptome studies in H. pylori.
| This study | Wen, etal 2003 | Merrell, etal 2003 | Ang, etal 2001 | Bury-Mone, etal 2004 | |
|---|---|---|---|---|---|
|
| |||||
| H. pylori strain | G-27 | 26695 | G-27 | NTU-D1 | 26695, SS1 |
| Transcriptome analysis | RNAseq | Fluorescent microarray | Fluorescent microarray | colometric microarray membrane | radiolabeled microarray membrane |
| media | BHI, YE | BHI | Brucella broth + 10% FBS | Columbia agar, 5% sheep blood | BHI, 0.2% β-cyclodextrin, antibiotic/fungicide mix |
| pH | 7.4, 6.0, 4.5, 3.0 | 7.4, 6.2, 5.5, 4.5 | 5.0 | 7.2, 5.5 | 7.0, 5.0 |
| pH stat | yes | no | no | no | no |
| Urea concentration | 5 mM | +/− 5 mM | 0 mM | 0 mM | 0 mM |
| Time | 4 hours | 30 minutes | 0,30, 60, 90, 120 minutes | 48 hours | 4 hrs (pH 7.0), 9 hrs (pH 5.0) |
| Atmosphere | 10% CO2, 5% O2, 85% N2 | 10% CO2, 5% O2, 85% N2 | 1 microaerobic | 10% CO2, 5% O2, 85% N2 | 1 microaerobic |
gas concentrations not provided
The hybridization-based microarray approaches used to define the H. pylori acid transcriptome have several disadvantages that are overcome using NGS RNAsequencing (RNAseq). Hybridization-based approaches require synthesizing labeled cDNA that is then hybridized to custom-made microarrays or commercial high-density oligo microarrays. Hybridization-based approaches require knowledge about genome sequence to synthesize probes. Cross hybridization and limited dynamic range (~100 fold) increase background levels and signal saturation. In contrast, NGS RNAseq directly determines the cDNA sequence, abrogating the need for labeled probes and hybridization biases and resulting in a dynamic range of >8000 fold.
In this work, our aim is to more accurately define the Helicobacter pylori acid transcriptome and use this information to better understand the cascade of events that allow H. pylori to colonize the stomach. We performed RNA-seq analysis at pH values of 3.0, 4.5, 6.0 compared with non-acidic pH in the presence of 5 mM urea after 4 hours of incubation to approximate in vivo conditions. We used a novel incubation system that maintains the urea concentration and pH at a constant level. Acid exposure induced the transcription of about 250 genes at all acidic pHs studied and about the same number were repressed. These data show the improvement in analysis by RNA-seq compared with microarray methods. Under this more physiologic incubation system, the exposure to acidity triggers not only the acid acclimation response, but also a cascade of other critical pathogenic factors that aide in gastric colonization.
Materials and Methods
Bacterial strains and culture conditions
H. pylori strain G27 was used (14, 15). Bacteria were grown under microaerobic conditions (5% O2, 10% CO2, 85% N2) in a mixed gas incubator on Trypticase Soy Agar (TSA) plates supplemented with 5% sheep blood (Gibco). For broth culture, H. pylori strain G27 was grown in brain heart infusion (BHI) medium (Difco) supplemented with 7% horse serum (Gibco), 0.25% yeast extract (Difco) and Dent selective supplement (Oxoid). The pH of the liquid culture was adjusted by the addition of HCl (pHs 3.0, 4.5, and 6.0) or NaOH as appropriate. Non-acidic pH used for all experiments was either 7.4 or 8.0. pH 8.0 is the upper limit of the range of survival and growth of a neutralophile.
RNA isolation
Bacteria from three plates were suspended in 3.5 mL BHI, and 0.5 mL of the bacterial suspension was added to each of four dialysis cassettes. Dialysis cassettes (Slide-A-Lyzer, MWCO 10kD) were suspended in 750 mL media at pH 3.0, 4.5, 6.0, 7.4, or 8.0 with 5 mM urea. Following incubation at each pH for 4 hours, RNA was isolated from H. pylori using a combination of the TRIzol® method and the RNeasy kit (Qiagen) as described previously (10). RNA quality was determined using an Agilent 2100 bioanalyzer. Only RNA with an RNA integrity number greater than 8 was used for analysis. Biologic replicates (3X) were completed for all experiments. For qPCR experiments, the starting material was scaled up proportionally to allow for filling of 4 cassettes with bacteria at each pH. One cassette at each pH was removed at 30 minutes, 1,2, and 4 hours, and the RNA was isolated and quality confirmed as above. The pH of the incubation media was unchanged after 4 hours for all experiments.
RNAseq analysis
Total RNA was extracted and stored at −80 °C until use. All RNA-sequencing and alignment procedures were conducted by ChunLab (Seoul, South Korea). The Ribo-Zero rRNA removal kit (Epicentre, USA) was used for ribosomal RNA depletion according to manufacturer instructions. Libraries for Illumina sequencing were made with the TruSeq Stranded mRNA sample prep kit (Illumina, USA) following the manufacturer’s protocol. RNA sequencing was performed on the Illumina HiSeq 2500 platform using single-end 50bp sequencing.
The sequence data for the reference genome (G27) was retrieved from the NCBI database. Quality-filtered reads were aligned to the reference-genome sequence using Bowtie2. The relative transcript abundance was measured in fragments in reads per kilobase of exon sequence per million mapped sequence reads (FPKM). Visualization of mapping results and differentially expressed gene (DEG) analysis were performed using the CLRNASeqTM program (ChunLab, South Korea). RNAseq experiments were completed at two non-acidic pHs, pH 8.0 and 7.4. pH 7.4 data was used for all ratios shown in the results section, but there was no significant difference in expression between pH 8.0 and pH 7.4 (data not shown).
Quantitative PCR
One step qRT-PCR was completed from RNA with the qScript One-Step SYBR® Green qRT-PCR Kit (Quanta Biosciences), using a Bio-Rad iCycler CFX-96 machine. Primer design was aided by the Primer3 software available at http://www-genome.wi.mit.edu/genomesoftware/other/primer3.html (16). Unique primers were designed for 100–300 base pair regions of each gene in the urease gene cluster and a housekeeping gene (Table 2).
Table 2.
Primer sequences used-used for qPCR
| Gene name | NCBI Reference | HP G27 ID | Sense (5′-3′) | Anti-sense (5′-3′) |
|---|---|---|---|---|
| ureA | HP0073 | HPG27_RS00385 | AACCGGATGATGTGATGGAT | GGTCTGTCGCCAACATTTTT |
| ureB | HP0072 | HPG27_RS00380 | CTTGGCAAACAGCTGACAAA | GTTGGGTTTTACGCCAAAGA |
| ureI | HP0071 | HPG27_RS00375 | TTCCTGCTGCGATTTTATCC | CATCTCACACCCAGTGTTGG |
| ureE | HP0070 | HPG27_RS00370 | CAAGTTGGGGCTCTCTCAAG | GTGGGCTTTTCAAATGGTGT |
| ureF | HP0069 | HPG27_RS00365 | TGCGCAAACTTCTAACATGG | GCATCGCCTTAATGTCGTTT |
| ureG | HP0068 | HPG27_RS00360 | GGTAAAACCGCCTTGATTGA | CGGACAGCCTCCTGTTTCTA |
| ureH | HP0067 | HPG27_RS00355 | TGCAATTAAACATCGGTCCA | CGTGGTGTTGCCCTTAAAAT |
| gyrB | HP0501 | HPG27_RS02415 | GAAAGCGTGATGGAAGTCGT | GAAATAATGGGGGTGAGCAA |
Standard PCR performed with genomic DNA from H. pylori strain G27 as the template was used to assure that all primer pairs resulted in amplification of a single product (data not shown). qPCR was completed using 10 QL reactions in a 96 well plate using the standard cycling protocol, conditions were 50o for 10 minutes, 95° for 5 minutes, followed by 45 cycles of 95o for 10 seconds, 60o for 30 seconds (data collection). Threshold cycle was calculated using the Bio-Rad software. A melting curve was used at the end of the run to confirm that there was only one peak and only one product for each primer. Results were analyzed using the comparative CT method (16, 17) with gyrB used as a housekeeping gene. RNA isolation was completed two times for each condition, and each RNA sample was run in triplicate. Non-acidic pH (pH 7.4) was used as the denominator for comparison with acidic pHs (pH 3.0, 4.5, and 6.0).
SDS-PAGE and Western blotting
Two plates of H. pylori strain G27 were suspended in 7 mL BHI and 3 mL of suspension was added to two dialysis cassettes as described above. Bacteria were incubated in the dialysis cassettes suspended in 750 mL of media at pH 6.0 or 8.0 with 5 mM urea for 4 hours. Bacteria were then pelleted at 10,000 rcf, 4°C for 5 minutes. Bacterial pellets were resuspended in 2 mL ice cold lysis buffer (ProNET Live!, ESI Source Solutions, LLC) containing 150 QL bacterial protease inhibitor (Sigma). Bacteria were lysed by 3 passes through a French Press at 20,000 p.s.i. Unbroken bacteria were harvested by a 10-minute spin at 4°C, 1500 rcf. The supernate fraction was collected as total bacterial lysate. Protein concentration was determined by the BCA method (Pierce/Thermo).
The bacterial lysates were size fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using 4–12% NuPAGE bis-tris gradient gels (Life Technologies) and transferred onto nitrocellulose (Bio-Rad). Western blot analysis was performed using antibodies against the periplasmic loops of UreI, GS1 and GS2, which were combined and used at a dilution of 1:500 (18). Secondary antibodies were horseradish peroxidase linked goat anti-rabbit (1:10,000, American Qualex). Protein bands were detected using SuperSignal West Pico Chemiluminescence Kit (Thermo). Immunoblots were quantified by densitometry using Image Studio Software (LI-COR Inc.).
Measurement of internal pH (pHin)
Internal (cytoplasmic) pH was measured using a fluorimeter as described previously (18). H. pylori grown overnight on TSA plates supplemented with 5% sheep blood (BD) were resuspended in BHI then added to each of four dialysis cassettes. Dialysis cassettes (Slide-A-Lyzer, MWCO 10kD) were suspended in 750 mL media at pH 3.0, 4.5, 6.0 or 8.0 with 5 mM urea and incubated for 4 hours as described above. After 3.5 hours, the membrane-permeant, pH-sensitive fluorescent probe 2,7-bis-(2-carboxyethyl)-5-carboxyfluorescein acetoxymethyl ester (BCECF-AM) was added to each of the bacterial suspensions to a final concentration of 10 QM. After four hours, the bacteria were pelleted by gentle centrifugation (2,000 × g, 5 minutes) and resuspended in 300 QL of HP medium (140 mM NaCl, 5 mM KCl, 1.3 mM CaCl2, 0.5 mM MgSO4, 10 mM glucose, 1 mM glutamine, 5 mM urea) at pH 3.0, 4.5, 6.0 or 8.0. To measure pHin, 100 QL of BCECF-loaded bacteria at each pH was added to 3 mL of 100 mM phosphate buffered HP medium of the same pH and fluorescence was monitored using a dual-excitation (Ex1; 502 nm, Ex2; 436 nm), single-emission (Em; 530 nm) fluorimeter (Jobin Yvon Horiba Fluorolog). Each experiment was calibrated independently. Once the fluorescence of the internal BCECF had been measured, 150 nM of the protonophore 3,3,4,5-tetrachlorosalicyanilide (TCS) was added to equilibrate the internal pH with that of the medium. HCl was then added to obtain minimum fluorescence of the dye, followed by the addition of NaOH to obtain maximum fluorescence of the dye. The internal pH was calculated using the equation:
where pKa = pKa of BCECF = 6.98, R = value at 502 nm/value at 436 nm for each data point, RA = ratio at minimum fluorescence, RB = ratio at maximum fluorescence, FA(λ2) = minimum fluorescence at 436 nm, and FB(λ2) = maximum fluorescence at 436 nm.
To determine if the FOF1-ATPase or oxidases contribute to proton extrusion in acid, pHin was monitored using BCECF in the presence and absence of the FOF1-atpase inhibitor N, N′-dicyclohexylcarbodiimide (DCCD) or the oxidation inhibitor (cytochrome bc), antimycin A. We hypothesized that if the FOF1-ATPase reverses in acid and extrudes protons, the cytoplasmic pH would increase and this increase would be abolished in the presence of DCCD. Bacteria grown overnight on TSA plates were resuspended in 5 ml BHI medium (Difco). BCECF-AM was added to the bacterial suspension to a final concentration of 5 QM. The bacterial suspension was then incubated in a microaerobic (5% O2, 10% CO2, 85% N2) environment at 37°C for 30 minutes with shaking. The bacteria were pelleted by gentle centrifugation (2,000 × g, 5 minutes) and resuspended in 300 QL of HP medium (140 mM NaCl, 5 mM KCl, 1.3 mM CaCl2, 0.5 mM MgSO4, 10 mM glucose, 1 mM glutamine) buffered with 1 mM phosphate buffer to pH 7.4. To measure pHin, 20QL of BCECF-loaded bacteria was added to 3 mL 100 mM phosphate buffered HP medium at pH 4.5, and fluorescence was monitored in the presence and absence of 100 nM DCCD or 10 μM antimycin A.
Results and Discussion
NH3 and H2CO3 generation
H. pylori is a neutralophile that encounters low pH at its site of infection, the gastric mucosa. Gastric colonization by H. pylori is facilitated by its ability to maintain periplasmic pH near neutrality in highly acidic environments through the mechanism of acid acclimation (19). Acid acclimation relies on the urease system (urease and its ancillary proteins including UreI, a proton gated urea channel), two carbonic anhydrases and perhaps other NH3+ or urea producing proteins (RocF, AmiE and AspA). The periplasm is buffered to a pH of 6.1 by NH3, produced through the hydrolysis of urea by urease, entering the periplasm from the cytoplasm and by HCO3− generation via carbonic anhydrase in the periplasm (20). However, measurement of cytoplasmic pH under identical conditions used for RNASeq analysis (pH 3.0, 4.5, 6.0 vs non-acidic pH for four hours) showed a progressive fall in cytoplasmic pH, reaching 6.2 at an external pH of 3.0 (Figure 1), suggesting that, in addition to sensing and responding to extracellular acidification, H. pylori gene expression is also dependent on cytoplasmic pH. The pHin of 7.8 at pH 8.0 indicates an outward proton gradient (21) however, at the acidic pH values used in this study, there is always an inward pH gradient.
Figure 1. The effect of external pH on cytoplasmic pH.
Measurement of cytoplasmic pH showed a progressive fall in cytoplasmic pH, reaching 6.1 at an external pH of 3.0. At this cytoplasmic pH (6.1), the pmf is almost entirely due to the Δψ. H. pylori was incubated for 4 hours at pH 3.0, 4.5, 6.0 and 8.0 in the presence of 5 mM urea. Cytoplasmic pH was measured using the pH-sensitive fluorescent dye BCECF-AM.
In the current study, RNA-seq analysis revealed that all the genes of the urease cluster increased transcription at pH 6.0 relative to pH 7.4, with the exception of ureF, which was not detected. The level of expression of these genes was maximal at pH 6.0, then declined with increasing acidity (Table 3). ureB and ureA transcripts were induced at pH 6.0 with respect to pH 7.4 by nearly 3 and 4-fold respectively. There was a threefold induction of the ureI transcript at pH 6.0 as compared to pH 7.4 (Table 3). Increased transcription of ureI was also reflected in the UreI protein abundance as determined by quantitative Western analysis (Figure 2). However, at pH 3, ureI transcription was not induced (1.48) and failed to reach statistical significance (p=0.16). Similarly, induction of ureE, ureG and ureH was maximal at pH 6.0 (Table 3). The pattern of expression of the urease genes is consistent with RNA degradation analysis in which the RNA was most stable at pH 6.0 or by acid induced auto-repression of the ArsRS two-component system (TCS) that regulates expression of the urease gene cluster (22, 23).
Table 3.
Acid regulated genes from Helicobacter pylori strain G27 determined by Differential Gene Expression RNAseq
| Gene name | NCBI Reference | Fold Change pH 3.0/7.4 | sem | p value | Fold Change pH 4.5/7.4 | sem | p value | Fold Change pH 6.0/7.4 | sem | p vlaue | a. | b. | c. | d. | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NH3 and H2CO3 generation | |||||||||||||||
| HPG27_RS00355 | HP0067 | 1.57 | 0.20 | 0.11 | 2.01 | 0.20 | 0.03 | 2.67 | 0.40 | 0.05 |
|
urease accessory protein (ureH) | |||
| HPG27_RS00360 | HP0068 | 1.93 | 0.22 | 0.05 | 2.27 | 0.23 | 0.02 | 3.45 | 0.52 | 0.04 |
|
urease accessory protein (ureG) | |||
| HPG27_RS00375 | HP0071 | 1.59 | 0.25 | 0.16 | 2.41 | 0.34 | 0.04 | 3.14 | 0.61 | 0.06 |
|
|
proton-gated urea channel (ureI) | ||
| HPG27_RS00380 | HP0072 | 1.08 | 0.10 | 0.49 | 1.69 | 0.17 | 0.05 | 4.12 | 1.02 | 0.09 |
|
urease beta-subunit (ureB) | |||
| HPG27_RS00385 | HP0073 | 1.34 | 0.07 | 0.04 | 1.95 | 0.17 | 0.02 | 2.76 | 0.37 | 0.03 |
|
|
urease alpha-subunit (ureA) | ||
| HPG27_RS03165 | HP0649 | −1.22 | 0.03 | 0.03 | −1.04 | 0.04 | 0.30 | 1.55 | 0.11 | 0.03 |
|
aspartate ammonia-lyase (aspA) | |||
| HPG27_RS05900 | HP1186 | 4.86 | 0.67 | 0.02 | 4.22 | 0.60 | 0.03 | 6.28 | 1.15 | 0.04 |
|
|
α-carbonic anhydrase (aca) | ||
| HPG27_RS07635 | HP1399 | 4.82 | 0.29 | 0.00 | 5.83 | 0.28 | 0.00 | 6.73 | 0.40 | 0.00 |
|
arginase (rocF) | |||
| HPG27_RS01475 | HP0294 | −1.91 | 0.10 | 0.04 | −1.25 | 0.16 | 0.28 | −1.02 | 0.16 | 0.47 |
|
|
|
aliphatic amidase (amiE) | |
| HPG27_RS06200 | HP1238 | −1.92 | 0.03 | 0.00 | −1.76 | 0.04 | 0.01 | −1.46 | 0.03 | 0.01 |
|
|
formamidase (amiF) | ||
| FOF1-ATPase | |||||||||||||||
| HPG27_RS04065 | HP0828 | 1.99 | 0.06 | 0.00 | 1.80 | 0.04 | 0.00 | 2.39 | 0.26 | 0.03 |
|
ATP-synthase Fo A subunit (atpB) | |||
| HPG27_RS05645 | HP1136 | 1.98 | 0.08 | 0.00 | 1.24 | 0.05 | 0.04 | −1.21 | 0.03 | 0.02 | ATP synthase Fo B subunit (atpF) | ||||
| HPG27_RS06075 | HP1212 | 1.57 | 0.13 | 0.04 | 2.10 | 0.14 | 0.00 | 2.21 | 0.14 | 0.00 | ATP synthase Fo C subunit (atpE) | ||||
| HPG27_RS05635 | HP1134 | 1.23 | 0.10 | 0.17 | 1.64 | 0.13 | 0.03 | 3.39 | 0.74 | 0.09 |
|
|
ATP synthase F1 α-subunit (atpA) | ||
| HPG27_RS05630 | HP1133 | 1.74 | 0.10 | 0.01 | 1.93 | 0.15 | 0.02 | 1.39 | 0.11 | 0.07 | ATP synthase F1 γ-subunit (atpG) | ||||
| HPG27_RS05640 | HP1135 | 2.09 | 0.08 | 0.00 | 1.59 | 0.04 | 0.00 | 1.44 | 0.06 | 0.01 | ATP synthase F1 δ-subunit (atpH) | ||||
| HPG27_RS05620 | HP1131 | 1.19 | 0.12 | 0.25 | 1.75 | 0.18 | 0.05 | 1.62 | 0.13 | 0.04 |
|
ATP synthase F1 ε-subunit (atpC) | |||
| Metabolism | |||||||||||||||
| TCA Pathway | |||||||||||||||
| HPG27_RS00145 | HP0026 | 1.31 | 0.05 | 0.01 | 1.71 | 0.12 | 0.02 | 2.82 | 0.48 | 0.06 | citrate synthase (gltA) | ||||
| HPG27_RS03800 | HP0779 | −2.15 | 0.03 | 0.00 | −1.36 | 0.03 | 0.00 | 1.16 | 0.09 | 0.20 | aconitase B (acnB) | ||||
| HPG27_RS00150 | HP0027 | 1.64 | 0.12 | 0.03 | 1.98 | 0.09 | 0.00 | 2.82 | 0.20 | 0.00 | isocitrate dehydrogenase (icd) | ||||
| HPG27_RS02860 | HP0588 | 1.63 | 0.15 | 0.05 | 1.14 | 0.10 | 0.26 | −1.19 | 0.03 | 0.02 | OorD subunit of the 2-oxoglutarate oxidoreductase (oorD) | ||||
| HPG27_RS02865 | HP0589 | −1.03 | 0.04 | 0.36 | 1.15 | 0.04 | 0.04 | 1.92 | 0.21 | 0.05 | OorA subunit of the 2-oxoglutarate oxidoreductase (oorA) | ||||
| HPG27_RS02870 | HP0590 | −1.03 | 0.07 | 0.40 | 1.14 | 0.06 | 0.14 | 1.64 | 0.13 | 0.03 | OorB subunit of the 2-oxoglutarate oxidoreductase (oorB) | ||||
| HPG27_RS00965 | HP0191 | −1.52 | 0.03 | 0.00 | −1.22 | 0.02 | 0.01 | 1.13 | 0.04 | 0.09 | fumarate reductase, iron-sulfur subunit (frdB) | ||||
| HPG27_RS00970 | HP0192 | −2.56 | 0.04 | 0.00 | −1.88 | 0.05 | 0.00 | −1.19 | 0.02 | 0.01 | fumarate reductase, flavoprotein subunit (frdA) | ||||
| HPG27_RS06665 | HP1325 | −1.55 | 0.04 | 0.02 | 0.94 | 0.06 | 0.27 | 2.26 | 0.45 | 0.11 | fumarase (fumC) | ||||
| HPG27_RS00450 | HP0086 | 1.35 | 0.16 | 0.17 | 1.63 | 0.12 | 0.02 | 2.88 | 0.52 | 0.07 | Malate:quinone oxireductase (mqo) | ||||
| HPG27_RS05490 | HP1108 | −1.29 | 0.06 | 0.06 | −1.20 | 0.03 | 0.02 | 1.04 | 0.05 | 0.34 | pyruvate flavodoxin oxidoreductase g-subunit gamma (porG, porC) | ||||
| HPG27_RS05495 | HP1109 | −1.19 | 0.04 | 0.05 | 1.00 | 0.02 | 0.46 | 1.40 | 0.10 | 0.06 | pyruvate flavodoxin oxidoreductase d-subunit (porD) | ||||
| HPG27_RS05500 | HP1110 | −1.54 | 0.05 | 0.01 | −1.15 | 0.04 | 0.10 | 1.54 | 0.19 | 0.11 | pyruvate flavodoxin oxidoreductase a-subunit alpha (porA) | ||||
| HPG27_RS05505 | HP1111 | 1.06 | 0.08 | 0.37 | 1.36 | 0.05 | 0.01 | 2.08 | 0.18 | 0.02 | pyruvate ferredoxin oxidoreductase, b-subunit (porB) | ||||
| HPG27_RS00620 | HP0121 | 1.42 | 0.03 | 0.00 | 1.68 | 0.04 | 0.00 | 2.20 | 0.21 | 0.02 | phosphoenolpyruvate synthase (ppsA) | ||||
| HPG27_RS01390 | HP0277 | −1.26 | 0.11 | 0.20 | −1.79 | 0.09 | 0.03 | −2.11 | 0.07 | 0.01 |
|
ferredoxin (fdxB) | |||
| Entner-Doudoroff Pathway | |||||||||||||||
| HPG27_RS05455 | HP1101 | 1.77 | 0.18 | 0.05 | 1.47 | 0.15 | 0.10 | 1.90 | 0.09 | 0.00 | glucose-6-phosphate 1-dehydrogenase (zwf, g6pD) | ||||
| HPG27_RS05450 | HP1100 | 1.44 | 0.04 | 0.00 | 1.66 | 0.04 | 0.00 | 2.04 | 0.08 | 0.00 |
|
phosphogluconate dehydratase (edd) | |||
| HPG27_RS05445 | HP1099 | 1.98 | 0.11 | 0.00 | 2.44 | 0.10 | 0.00 | 2.64 | 0.12 | 0.00 |
|
2-keto-3-deoxy-6-phosphogluconate aldolase (eda) | |||
| Glycolysis | |||||||||||||||
| HPG27_RS05840 | HP1174 | 3.97 | 0.59 | 0.03 | 5.01 | 0.83 | 0.03 | 6.64 | 1.37 | 0.05 |
|
glucose/galactose transporter (gluP) | |||
| HPG27_RS05465 | HP1103 | 0.67 | 0.05 | 0.02 | 0.73 | 0.06 | 0.04 | 0.99 | 0.03 | 0.43 | glucokinase (glk) | ||||
| HPG27_RS05800 | HP1166 | −1.22 | 0.07 | 0.13 | −1.02 | 0.08 | 0.44 | 1.54 | 0.09 | 0.02 |
|
glucose-6-phosphate isomerase (pgi) | |||
| HPG27_RS00885 | HP0176 | 2.08 | 0.06 | 0.00 | 2.49 | 0.10 | 0.00 | 2.77 | 0.21 | 0.01 | fructose-bisphosphate aldolase (fba, tsr) | ||||
| HPG27_RS00980 | HP0194 | 1.38 | 0.10 | 0.06 | 1.31 | 0.08 | 0.06 | 1.17 | 0.03 | 0.02 | triosephosphate isomerase (tpi) | ||||
| HPG27_RS04500 | HP0921 | −1.49 | 0.08 | 0.05 | −1.85 | 0.07 | 0.02 | −1.58 | 0.04 | 0.01 | glyceraldehyde-3-phosphate dehydrogenase (gap1, gap) | ||||
| HPG27_RS06770 | HP1346 | −1.46 | 0.03 | 0.01 | −1.51 | 0.02 | 0.00 | −1.13 | 0.04 | 0.12 | glyceraldehyde-3-phosphate dehydrogenase (gap2, gap) | ||||
| HPG27_RS06765 | HP1345 | 1.62 | 0.06 | 0.00 | 1.53 | 0.07 | 0.01 | 1.86 | 0.18 | 0.04 | phosphoglycerate kinase (pgk) | ||||
| HPG27_RS04785 | HP0974 | −1.40 | 0.01 | 0.00 | −1.53 | 0.03 | 0.00 | −1.52 | 0.03 | 0.00 | 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (pgm) | ||||
| HPG27_RS00780 | HP0154 | −2.40 | 0.05 | 0.00 | −1.71 | 0.06 | 0.01 | −1.24 | 0.04 | 0.03 | enolase (eno) | ||||
| HPG27_RS00620 | HP0121 | 1.42 | 0.03 | 0.00 | 1.68 | 0.04 | 0.00 | 2.20 | 0.21 | 0.02 | phosphoenolpyruvate synthase (ppsA) | ||||
| HPG27_RS07690 | HP1385 | 2.13 | 0.04 | 0.00 | 2.30 | 0.07 | 0.00 | 3.23 | 0.29 | 0.01 | fructose 1,6-bisphosphatase (fbp) | ||||
| pentose phosphate pathway | |||||||||||||||
| HPG27_RS05460 | HP1102 | 0.95 | 0.07 | 0.38 | 0.77 | 0.06 | 0.07 | 0.81 | 0.03 | 0.02 | 6-phosphogluconolactonase (pgl, devB) | ||||
| HPG27_RS07685 | HP1386 | −1.50 | 0.07 | 0.04 | −1.92 | 0.05 | 0.01 | −2.21 | 0.07 | 0.01 |
|
ribulose-phosphate 3-epimerase (rpe) | |||
| HPG27_RS07415 | HP1495 | 1.89 | 0.16 | 0.03 | 1.75 | 0.22 | 0.08 | 2.44 | 0.48 | 0.11 | transaldolase (tal) | ||||
| HPG27_RS01820 | HP1088 | 0.65 | 0.06 | 0.03 | 0.62 | 0.07 | 0.02 | 0.74 | 0.04 | 0.01 | transketolase (tktA) | ||||
| Antioxidant genes | |||||||||||||||
| HPG27_RS00690 | HP0136 | 1.16 | 0.05 | 0.09 | 1.32 | 0.05 | 0.01 | 1.64 | 0.16 | 0.05 | peroxiredoxin, bacterioferritin comigratory protein (bcp) | ||||
| HPG27_RS01125 | HP0224 | 1.49 | 0.09 | 0.03 | 2.00 | 0.05 | 0.00 | 2.67 | 0.25 | 0.01 | methionine sulfoxide reductase (msrA) | ||||
| HPG27_RS01220 | HP0243 | 1.17 | 0.08 | 0.18 | 1.53 | 0.11 | 0.03 | 2.57 | 0.28 | 0.02 | neutrophil activating protein (bacterioferritin) (napA) | ||||
| HPG27_RS05265 | HP0389 | 2.84 | 0.15 | 0.00 | 3.22 | 0.17 | 0.00 | 4.89 | 0.71 | 0.02 | superoxide dismutase (sodB, sodF) | ||||
| HPG27_RS04050 | HP0825 | 1.94 | 0.21 | 0.04 | 2.33 | 0.22 | 0.02 | 2.97 | 0.41 | 0.04 |
|
thioredoxin reductase (trxR1, trxB) | |||
| HPG27_RS04280 | HP0875 | 2.23 | 0.14 | 0.00 | 2.60 | 0.16 | 0.00 | 4.79 | 0.75 | 0.03 | catalase (katA) | ||||
| HPG27_RS05790 | HP1164 | 1.73 | 0.12 | 0.02 | 1.71 | 0.18 | 0.06 | 1.58 | 0.10 | 0.02 | thioredoxin reductase (trxR2, trxB) | ||||
| HPG27_RS07230 | HP1458 | 1.14 | 0.20 | 0.40 | 1.15 | 0.14 | 0.35 | 1.66 | 0.12 | 0.02 |
|
thioredoxin (trx2) | |||
| Motility | |||||||||||||||
| class 3 flagellar genes | |||||||||||||||
| HPG27_RS01995 | HP1051 | 2.73 | 0.32 | 0.03 | 2.66 | 0.47 | 0.07 | 1.37 | 0.07 | 0.02 | hypothetical protein | ||||
| HPG27_RS01990 | HP1052 | 1.88 | 0.13 | 0.01 | 1.81 | 0.07 | 0.00 | 1.95 | 0.08 | 0.00 | UDP-3-0-acyl N-acetylglycosamine deacetylase (envA) | ||||
| intermediate class flagellar genes | |||||||||||||||
| HPG27_RS03665 | HP0753 | 2.39 | 0.11 | 0.00 | 1.98 | 0.14 | 0.01 | 1.41 | 0.10 | 0.05 | flagellar biosynthesis protein (fliS) | ||||
| HPG27_RS03675 | HP0754 | −1.07 | 0.04 | 0.21 | −1.16 | 0.03 | 0.05 | −1.67 | 0.06 | 0.02 | flagellar chaperone (fliT) | ||||
| HPG27_RS05575 | HP1122 | 1.97 | 0.15 | 0.01 | 1.02 | 0.07 | 0.48 | −1.42 | 0.06 | 0.04 |
|
anti-sigma factor (flgM) | |||
| HPG27_RS07805 | HP1557 | 2.43 | 0.19 | 0.01 | 1.30 | 0.13 | 0.15 | −1.23 | 0.05 | 0.08 |
|
flagellar hook-basal body complex protein (fliE) | |||
| HPG27_RS07815 | HP1559 | −1.41 | 0.04 | 0.01 | −1.47 | 0.06 | 0.03 | −1.96 | 0.09 | 0.02 |
|
|
flagellar biosynthesis protein (flgB) | ||
| HPG27_RS00830 | HP0165 | 1.11 | 0.03 | 0.07 | −1.34 | 0.03 | 0.01 | −1.62 | 0.05 | 0.01 | histidine kinase (arsS) | ||||
| HPG27_RS00835 | HP0166 | −1.42 | 0.10 | 0.10 | −1.73 | 0.08 | 0.03 | −1.78 | 0.07 | 0.02 | response regulator (arsR) | ||||
| HPG27_RS05535 | HP0488 | −1.20 | 0.09 | 0.17 | −1.21 | 0.07 | 0.11 | −1.81 | 0.07 | 0.02 | hypothetical protein | ||||
| HPG27_RS07135 | HP1440 | −1.91 | 0.04 | 0.00 | −2.33 | 0.05 | 0.00 | −2.17 | 0.06 | 0.01 |
|
|
hypothetical protein | ||
| class 2 flagelllar genes | |||||||||||||||
| HPG27_RS04430 | HP0906 | 1.42 | 0.26 | 0.24 | 1.89 | 0.24 | 0.06 | 1.81 | 0.20 | 0.05 | hypothetical protein | ||||
| HPG27_RS00600 | HP0115 | 1.56 | 0.27 | 0.18 | 2.56 | 0.35 | 0.04 | 3.23 | 0.51 | 0.04 |
|
|
flagellin B (flaB) | ||
| HPG27_RS01480 | HP0295 | 1.31 | 0.22 | 0.27 | 1.43 | 0.13 | 0.09 | 1.76 | 0.18 | 0.04 |
|
flagellar hook-associated protein (flgL) | |||
| HPG27_RS01870 | HP1076 | 3.48 | 0.88 | 0.11 | 2.84 | 0.57 | 0.09 | 2.16 | 0.20 | 0.02 |
|
hypothetical protein | |||
| HPG27_RS05740 | HP1154 | 2.63 | 0.71 | 0.16 | 2.17 | 0.40 | 0.11 | 2.12 | 0.26 | 0.05 |
|
flagellar assembly protein (flaW) | |||
| class 1 flagellar genes | |||||||||||||||
| HPG27_RS00520 | HP0099 | 1.37 | 0.09 | 0.05 | 1.46 | 0.08 | 0.02 | 2.25 | 0.17 | 0.01 | methyl-accepting chemotaxis transmembrane sensory protein (tlpA) | ||||
| HPG27_RS00540 | HP0103 | −1.26 | 0.04 | 0.04 | 1.25 | 0.05 | 0.03 | 1.66 | 0.14 | 0.03 | methyl-accepting chemotaxis transmembrane sensory protein (tlpB) | ||||
| HPG27_RS00870 | HP0173 | −1.32 | 0.13 | 0.19 | −1.87 | 0.08 | 0.02 | −2.08 | 0.06 | 0.01 | flagellar biosynthesis protein (fliR) | ||||
| HPG27_RS01225 | HP0244 | 1.79 | 0.05 | 0.00 | 1.35 | 0.08 | 0.05 | −1.03 | 0.06 | 0.41 | histidine kinase (flgS) | ||||
| HPG27_RS01235 | HP0246 | −1.22 | 0.06 | 0.09 | −1.72 | 0.07 | 0.02 | −1.93 | 0.07 | 0.02 | flagellar P-ring protein (flgl) | ||||
| HPG27_RS01635 | HP0325 | −1.73 | 0.07 | 0.02 | −1.83 | 0.07 | 0.01 | −1.54 | 0.03 | 0.00 |
|
flagellar L-ring protein (flgH) | |||
| HPG27_RS05250 | HP0392 | −1.07 | 0.04 | 0.19 | 1.05 | 0.05 | 0.33 | 1.50 | 0.10 | 0.03 | chemotaxis protein A (cheA) | ||||
| HPG27_RS05245 | HP0393 | −1.57 | 0.02 | 0.00 | −1.78 | 0.03 | 0.00 | −1.76 | 0.06 | 0.01 |
|
chemotaxis protein (cheY) | |||
| HPG27_RS02835 | HP0584 | −1.24 | 0.02 | 0.01 | −1.60 | 0.01 | 0.00 | −2.05 | 0.06 | 0.01 | flagellar motor switch protein (fliN) | ||||
| HPG27_RS02915 | HP0599 | 1.14 | 0.02 | 0.01 | 1.28 | 0.02 | 0.00 | 1.94 | 0.20 | 0.04 | chemotaxis receptor (tlpB) | ||||
| HPG27_RS02995 | HP0616 | −1.68 | 0.04 | 0.01 | −1.72 | 0.07 | 0.02 | −1.78 | 0.07 | 0.02 | chemotaxis protein (cheV) | ||||
| HPG27_RS03320 | HP0685 | 1.12 | 0.08 | 0.26 | −1.43 | 0.04 | 0.02 | −2.01 | 0.04 | 0.00 | flagellar biosynthesis protein (fliP) | ||||
| HPG27_RS03460 | HP0714 | −1.21 | 0.18 | 0.30 | −1.70 | 0.09 | 0.04 | −1.66 | 0.06 | 0.03 | RNA polymerase sigma54 factor (rpoN) | ||||
| HPG27_RS03980 | HP0815 | −1.68 | 0.09 | 0.05 | −1.69 | 0.08 | 0.03 | −1.60 | 0.07 | 0.03 | motility protein A (motA) | ||||
| HPG27_RS03985 | HP0816 | −1.46 | 0.09 | 0.08 | −1.64 | 0.05 | 0.01 | −1.72 | 0.04 | 0.01 |
|
flagellar motor proteinB (motB) | |||
| HPG27_RS04125 | HP0840 | −1.32 | 0.10 | 0.15 | −1.30 | 0.08 | 0.11 | −1.61 | 0.04 | 0.01 | flagella associated protein (flaA1) | ||||
| HPG27_RS02045 | HP1041 | −1.16 | 0.11 | 0.27 | −1.46 | 0.09 | 0.08 | −1.70 | 0.08 | 0.03 | flagellar biosynthesis protein (flhA) | ||||
| HPG27_RS01910 | HP1067 | 1.74 | 0.09 | 0.01 | −1.11 | 0.04 | 0.14 | −1.42 | 0.09 | 0.08 |
|
chemotaxis protein (cheY) | |||
| HPG27_RS06480 | HP1286 | 1.02 | 0.07 | 0.46 | 1.60 | 0.08 | 0.01 | 2.28 | 0.35 | 0.07 | FliZ protein (fliZ) | ||||
| HPG27_RS07030 | HP1420 | −1.71 | 0.03 | 0.00 | −1.44 | 0.04 | 0.02 | −1.70 | 0.02 | 0.00 | flagellum-specific ATP synthase (flil) | ||||
| HPG27_RS07135 | HP1440 | −1.91 | 0.04 | 0.00 | −2.33 | 0.05 | 0.00 | −2.17 | 0.06 | 0.01 |
|
|
hypothetical protein | ||
| HPG27_RS07250 | HP1462 | 2.69 | 0.52 | 0.08 | 2.50 | 0.40 | 0.06 | 1.81 | 0.18 | 0.03 | flagellar motility secretory protein | ||||
| HPG27_RS07895 | HP1575 | −1.51 | 0.08 | 0.05 | −1.66 | 0.09 | 0.04 | −1.96 | 0.08 | 0.02 | flagellar biosynthesis protein (flhB/ylqH) | ||||
| HPG27_RS07945 | HP1585 | −2.16 | 0.07 | 0.01 | −2.31 | 0.06 | 0.00 | −2.37 | 0.06 | 0.01 | flagellar basal body rod protein (flgG) | ||||
| other | |||||||||||||||
| HPG27_RS05160 | HP0410 | 1.45 | 0.03 | 0.00 | 1.53 | 0.04 | 0.00 | 2.07 | 0.19 | 0.02 | neuraminyllactose-binding hemagglutinin (hpaA2) | ||||
| HPG27_RS02370 | HP0492 | 1.55 | 0.11 | 0.03 | 1.29 | 0.07 | 0.05 | 1.40 | 0.06 | 0.02 | flagellar sheath associated protein paralog (hpa3) | ||||
| HPG27_RS03890 | HP0797 | 2.34 | 0.11 | 0.00 | 3.06 | 0.20 | 0.00 | 4.62 | 0.68 | 0.03 | neuraminyllactose-binding hemagglutinin (hpaA) | ||||
| Outer membrane proteins | |||||||||||||||
| hop genes | |||||||||||||||
| HPG27_RS00060 | HP0009 | 1.33 | 0.07 | 0.03 | 1.81 | 0.05 | 0.00 | 2.62 | 0.30 | 0.03 |
|
outer membrane protein HopZ (hopZ, omp1) | |||
| HPG27_RS04380 | HP0317 | −1.93 | 0.05 | 0.02 | −1.56 | 0.06 | 0.04 | −1.94 | 0.06 | 0.02 |
|
outer membrane protein HopU (hopU, omp9, babC) | |||
| HPG27_RS03495 | HP0722 | 3.19 | 0.45 | 0.04 | 4.41 | 0.79 | 0.05 | 6.19 | 1.53 | 0.08 |
|
|
outer membrane protein HopO (hopO, omp16, sabB) | ||
| HPG27_RS03510 | HP0725 | 9.14 | 1.83 | 0.04 | 11.22 | 3.42 | 0.10 | 13.00 | 4.12 | 0.11 |
|
|
outer membrane protein HopP (hopP, omp17, sabA) | ||
| HPG27_RS04465 | HP0912 | 1.42 | 0.10 | 0.04 | 2.05 | 0.11 | 0.00 | 4.30 | 0.91 | 0.07 |
|
outer membrane protein HopC (hopC, alpA, omp20) | |||
| HPG27_RS04470 | HP0913 | 1.20 | 0.06 | 0.08 | 2.34 | 0.22 | 0.02 | 4.23 | 0.94 | 0.08 |
|
outer membrane protein HopB (hopB, alpB, omp21) | |||
| HPG27_RS05850 | HP1177 | 1.73 | 0.13 | 0.02 | 1.97 | 0.19 | 0.03 | 2.42 | 0.37 | 0.06 |
|
|
|
outer membrane protein HopQ (hopQ, omp27) | |
| HPG27_RS06750 | HP1342 | −6.21 | 0.01 | 0.00 | −3.09 | 0.07 | 0.00 | −2.70 | 0.09 | 0.01 | outer membrane protein HopN2 (hopN, omp29) | ||||
| hor genes | |||||||||||||||
| HPG27_RS01630 | HP0324 | 1.52 | 0.08 | 0.01 | 1.25 | 0.03 | 0.00 | 1.18 | 0.04 | 0.04 | outer membrane protein HorC (horC, omp10) | ||||
| HPG27_RS03885 | HP0796 | 3.01 | 0.45 | 0.04 | 2.88 | 0.58 | 0.08 | 1.04 | 0.07 | 0.45 |
|
outer membrane protein HorG (horG, omp18) | |||
| HPG27_RS01915 | HP1066 | −1.69 | 0.04 | 0.01 | −1.50 | 0.05 | 0.02 | −1.78 | 0.09 | 0.04 | outer membrane protein HorD (horD) | ||||
| HPG27_RS05515 | HP1113 | −1.86 | 0.02 | 0.00 | −1.26 | 0.02 | 0.01 | −1.05 | 0.06 | 0.34 | outer membrane protein Horl (horl, omp24) | ||||
| HPG27_RS07650 | HP1395 | 2.55 | 0.18 | 0.00 | 3.08 | 0.22 | 0.00 | 3.75 | 0.41 | 0.01 |
|
outer membrane protein HorL (horL) | |||
| hof genes | |||||||||||||||
| HPG27_RS01055 | HP0209 | −1.64 | 0.03 | 0.00 | −1.59 | 0.03 | 0.00 | −1.69 | 0.05 | 0.01 | outer membrane protein HofA (hofA) | ||||
| HPG27_RS01845 | HP1083 | 1.87 | 0.23 | 0.07 | 2.07 | 0.26 | 0.05 | 1.88 | 0.16 | 0.03 | outer membrane protein HofB (hofB) | ||||
| HPG27_RS03815 | HP0782 | −1.50 | 0.08 | 0.05 | −1.71 | 0.07 | 0.02 | −1.97 | 0.07 | 0.01 | outer membrane protein HofE (hofE) | ||||
| hom genes | |||||||||||||||
| HPG27_RS04570 | HP0710 | 2.58 | 0.22 | 0.01 | 2.47 | 0.25 | 0.02 | 2.59 | 0.33 | 0.04 |
|
outer membrane protein HomA (homA) | |||
| FecA-like genes | |||||||||||||||
| HPG27_RS03325 | HP0686 | −2.79 | 0.06 | 0.00 | −2.37 | 0.07 | 0.01 | −2.01 | 0.08 | 0.02 | outer membrane protein (fecA-1) | ||||
| HPG27_RS03940 | HP0807 | −1.81 | 0.05 | 0.01 | −1.64 | 0.05 | 0.01 | −1.12 | 0.04 | 0.13 | outer membrane protein (fecA-2) | ||||
| HPG27_RS07505 | HP1512 | 0.98 | 0.04 | 0.39 | 1.15 | 0.04 | 0.08 | 1.50 | 0.07 | 0.01 |
|
outer membrane protein (frpB-3) | |||
| efflux pump genes | |||||||||||||||
| HPG27_RS02945 | HP0605 | 1.61 | 0.13 | 0.04 | 1.73 | 0.16 | 0.04 | 1.41 | 0.11 | 0.06 | outer-membrane protein of the hefABC efflux system (hefA) | ||||
| HPG27_RS04770 | HP0971 | −1.12 | 0.06 | 0.21 | −1.45 | 0.03 | 0.00 | −1.83 | 0.04 | 0.00 | outer membrane protein HefD | ||||
| HPG27_RS06675 | HP1327 | 1.49 | 0.15 | 0.08 | −1.17 | 0.03 | 0.05 | −1.57 | 0.07 | 0.03 | outer membrane protein HefG | ||||
| other omp genes | |||||||||||||||
| HPG27_RS03360 | HP0694 | −1.53 | 0.07 | 0.04 | −1.67 | 0.06 | 0.02 | −1.98 | 0.05 | 0.00 | outer membrane protein | ||||
| HPG27_RS03515 | HP0726 | −1.54 | 0.03 | 0.00 | −1.51 | 0.03 | 0.00 | −1.48 | 0.06 | 0.03 | outer membrane protein | ||||
| HPG27_RS03830 | HP0785 | 1.70 | 0.16 | 0.04 | 1.58 | 0.07 | 0.00 | 1.71 | 0.09 | 0.00 | outer-membrane lipoprotein carrier protein (lolA) | ||||
| HPG27_RS07275 | HP1467 | −1.65 | 0.07 | 0.03 | −1.62 | 0.06 | 0.03 | −1.67 | 0.06 | 0.02 |
|
outer membrane protein | |||
| HPG27_RS07835 | HP1564 | 2.71 | 0.55 | 0.09 | 3.29 | 0.54 | 0.04 | 3.80 | 0.69 | 0.05 | outer membrane lipoprotein (plpA) | ||||
| HPG27_RS01635 | HP0325 | −1.73 | 0.07 | 0.02 | −1.83 | 0.07 | 0.01 | −1.54 | 0.03 | 0.00 | outer membrane protein (flgH) | ||||
| HPG27_RS05595 | HP1125 | 1.62 | 0.03 | 0.00 | 1.44 | 0.03 | 0.00 | 1.55 | 0.05 | 0.00 | outer membrane protein (palA) | ||||
| Type 4 Secretion System (T4SS)/Cag pathogenicity island (PAI) | |||||||||||||||
| HPG27_RS02505 | HP0521 | 1.54 | 0.12 | 0.04 | 1.29 | 0.08 | 0.06 | −1.44 | 0.10 | 0.09 | cag pathogenicity island protein 2 (cag2) | ||||
| HPG27_RS02510 | HP0522 | 1.83 | 0.07 | 0.00 | 1.57 | 0.03 | 0.00 | 1.42 | 0.04 | 0.00 | cag pathogenicity island protein 3 (cag3) | ||||
| HPG27_RS02520 | HP0524 | 1.50 | 0.10 | 0.03 | 1.09 | 0.05 | 0.18 | 1.19 | 0.08 | 0.14 | cag pathogenicity island protein 5 (cag5) | ||||
| HPG27_RS02525 | HP0525 | 1.63 | 0.05 | 0.00 | 1.25 | 0.07 | 0.07 | 1.33 | 0.07 | 0.04 | cag pathogenicity island encoded (virB11) | ||||
| HPG27_RS02530 | HP0526 | 3.74 | 0.20 | 0.00 | 3.22 | 0.25 | 0.00 | 3.48 | 0.39 | 0.01 | cag pathogenicity island protein Z (cag6) | ||||
| HPG27_RS02545 | HP0529 | 1.53 | 0.13 | 0.05 | −1.09 | 0.06 | 0.26 | −1.46 | 0.07 | 0.04 | cag pathogenicity island protein W (cag9) | ||||
| HPG27_RS02555 | HP0531 | 1.07 | 0.04 | 0.20 | −1.45 | 0.03 | 0.00 | −1.50 | 0.06 | 0.02 | cag pathogenicity island protein U (cag11) | ||||
| HPG27_RS02560 | HP0532 | 2.70 | 0.12 | 0.00 | 2.34 | 0.13 | 0.00 | 2.44 | 0.16 | 0.00 |
|
cag pathogenicity island protein T (cag12) | |||
| HPG27_RS02565 | HP0534 | 2.47 | 0.18 | 0.00 | 1.77 | 0.11 | 0.01 | 2.08 | 0.16 | 0.01 | cag pathogenicity island protein S (cag13) | ||||
| HPG27_RS02580 | HP0535 | 2.43 | 0.10 | 0.00 | 1.99 | 0.05 | 0.00 | 1.91 | 0.07 | 0.00 | cag pathogenicity island protein Q (cag14) | ||||
| HPG27_RS02595 | HP0537 | −1.41 | 0.06 | 0.03 | −1.91 | 0.06 | 0.01 | −2.04 | 0.04 | 0.00 |
|
|
cag pathogenicity island protein M (cag16) | ||
| HPG27_RS02615 | HP0541 | 3.09 | 0.09 | 0.00 | 2.42 | 0.10 | 0.00 | 2.00 | 0.05 | 0.00 |
|
cag pathogenicity island protein H (cag20) | |||
| HPG27_RS02625 | HP0542 | 5.88 | 0.40 | 0.00 | 4.51 | 0.51 | 0.01 | 4.29 | 0.32 | 0.00 |
|
cag pathogenicity island protein G (cag21) | |||
| HPG 27_RS02630 | HP0543 | 6.50 | 0.90 | 0.01 | 5.34 | 0.71 | 0.01 | 7.09 | 1.05 | 0.02 |
|
cag pathogenicity island protein F (cag22) | |||
| HPG27_RS02640 | HP0545 | 2.28 | 0.15 | 0.00 | 2.23 | 0.22 | 0.02 | 2.24 | 0.18 | 0.01 | cag pathogenicity island protein D (cag24) | ||||
| HPG27_RS02650 | HP0546 | 2.15 | 0.24 | 0.04 | 1.15 | 0.09 | 0.22 | −1.31 | 0.12 | 0.18 | cag pathogenicity island protein C (cag25) | ||||
| HPG27_RS02655 | HP0547 | −1.61 | 0.11 | 0.08 | −1.30 | 0.12 | 0.19 | −1.04 | 0.07 | 0.41 | cag pathogenicity island protein A (cag26) | ||||
| Cell division | |||||||||||||||
| HPG27_RS01435 | HP0286 | −1.54 | 0.06 | 0.02 | −1.56 | 0.06 | 0.02 | −1.59 | 0.06 | 0.02 |
|
cell division protein (fstH) | |||
| HPG27_RS01985 | HP1053 | 1.87 | 0.30 | 0.11 | 1.94 | 0.22 | 0.05 | 1.91 | 0.19 | 0.03 | septum site-determining protein (minC) | ||||
| HPG27_RS01675 | HP0331 | 2.11 | 0.22 | 0.03 | 1.69 | 0.13 | 0.02 | 1.25 | 0.06 | 0.05 |
|
|
septum site-determining protein (minD) | ||
| HPG27_RS01680 | HP0332 | 1.99 | 0.16 | 0.01 | 1.45 | 0.16 | 0.12 | −1.24 | 0.08 | 0.15 | cell division topological specificity factor (minE) | ||||
| HPG27_RS03280 | HP0675 | −1.75 | 0.05 | 0.01 | −1.82 | 0.06 | 0.01 | −1.92 | 0.07 | 0.02 | tyrosine recombinase (xerC) | ||||
| HPG27_RS03645 | HP0749 | −1.20 | 0.07 | 0.15 | −1.50 | 0.06 | 0.02 | −1.51 | 0.05 | 0.02 | cell division protein (ftsX) | ||||
| HPG27_RS04805 | HP0978 | 1.49 | 0.10 | 0.03 | 1.54 | 0.10 | 0.02 | 2.01 | 0.21 | 0.03 | cell division protein (ftsA) | ||||
| HPG27_RS04810 | HP0979 | −2.01 | 0.06 | 0.01 | −1.91 | 0.05 | 0.01 | −1.51 | 0.03 | 0.01 | cell division protein (ftsZ) | ||||
| HPG27_RS01810 | HP1090 | −1.21 | 0.12 | 0.24 | −1.58 | 0.06 | 0.02 | −1.56 | 0.06 | 0.03 | cell division protein (ftsK) | ||||
| HPG27_RS01900 | HP1069 | 1.28 | 0.06 | 0.04 | 1.47 | 0.03 | 0.00 | 1.84 | 0.14 | 0.02 | cell diivision protein (ftsH) | ||||
Induced genes > 1.5 bold font, repressed genes <1.5 fold bold and italic font
Wen 2003
Merrell 2003
Ang 2001
Bury-mone 2004
Figure 2. UreI protein expression is pH dependent.
The protein level of UreI increased at pH 6.0 as compared to pH 8.0, reflecting the pattern of gene expression determined by RNA-seq analysis. (A.) Representative Western blot (1 blot with intervening lanes removed) of pH-dependent UreI expression. (B.) Densitometry analysis of UreI expression. H. pylori was incubated for 4 hours at pH 6.0 and 8.0 in the presence of 5 mM urea. n=3, error bars represent standard deviation.
The pH dependent transcription of the urease gene cluster revealed by RNAseq was confirmed by qRT-PCR. Figure 3 shows the expression ratio of pH 3.0, 4.5 and 6.0 with pH 8.0 as the denominator for ureB and ureI, with greater than a 2-fold change at 4 hours. In addition to pH dependent transcription changes of the urease gene cluster, we also wanted to know if the discrepancies among the various acid transcriptome studies was a function of incubation time (10–13). H. pylori was incubated at pH 3.0, 4.5, 6.0 and 8.0 for 30, 60, 120 and 240 minutes followed by qPCR for the detection of genes in the urease operon. ureB and ureI gene expression was unchanged when acid challenged for up to two hours. However, ureB and ureI gene expression increased greater than 3-fold after 4 hours of incubation. This pattern of expression was similar for the other members of the urease gene cluster. These results explain that the differences in acid dependent gene transcription among the various transcriptomal studies is at least partially due to length of acid exposure. For example, the genes of the urease operons were highly induced in vivo, where H. pylori is continually exposed to acid, while 30 minutes of acid exposure in the presence of urea resulted in no change in transcript levels (9, 10).
Figure 3. Expression of urease gene cluster genes increases over time at acidic pH.
RT-qPCR was completed after incubation of H. pylori at pH 3.0, 4.5, 6.0, and 8.0 for the indicated time periods. ureB is shown in (A.) and ureI is shown in (B.). Both genes showed >2-fold increase in expression in acid at the four-hour time point, with minimal to no change prior to this time. Error bars represent standard deviation, n=3.
The urease gene cluster is composed of 2 operons, PureA and PureI (23). The PureA promoter regulates gene transcription of ureA and ureB, encoding the catalytic subunits of urease, while PureI regulates the transcription of the urease accessory genes (ureE-ureH), which encode proteins needed for nickel insertion into apoenzyme and ureI, encoding for a proton-gated urea channel. In turn, the ure-promoters are regulated by the ArsRS TCS. The ArsRS TCS responds to periplasmic acidity via protonation of His94 of ArsS (HP0165, gene numbers in the text refer to the ATCC 26695 reference strain (24)), resulting in auto-phosphorylation and subsequent phospho-transfer to Asp52 of its cognate response regulator ArsR (HP0166) (25). Phosphorylation of ArsR leads to increased transcription of the urease genes and decreased transcription of arsS and arsR genes encoding for the ArsRS TCS (Table 3).
The transcriptional analysis of the genes encoding α-carbonic anhydrase (aca) and arginase (rocF) in response to changes in pH was somewhat different from the response of the urease gene cluster. Transcription remained high at both pH 4.5 and 3.0, suggesting another level of regulation, possibly through the cytoplasmic histidine kinase, FlgS (26). α-carbonic anhydrase is required for buffering of the periplasm since the pKa of the NH4+/NH3 couple is too high (9.26) for effective buffering at pH of ~6.1, the periplasmic pH in the presence of urea when the pHout ranges from 3.0–6.0. Arginase produces urea used either as a nitrogen source or a safety measure in case gastric juice urea becomes too low. Arginine is not required for acid acclimation in vivo but is necessary in vitro in the absence of urea (27).
The ammonia producing enzyme, aspartate-ammonia lyase (aspA) was mildly induced (1.54 fold) as the pH decreased form non-acidic to pH 6.0 but not at pH 4.5 or 3.0. The ammonia producing formamidase (amiF) was repressed as acidity increased. Acid repression of amiF contrasts with previous acid transcriptome analyses by Merrell etal and Ang etal, which showed amiF induction (11, 13). In the current study, in contrast with prior work, 5 mM urea was included in the incubation medium, suggesting that urease activity produces sufficient ammonia to combat acidity and AmiF is only needed when urease activity is insufficient to raise periplasmic pH in acid due to low gastric urea concentrations. The other ammonia producing enzymes, peptidyl-arginine deiminase (pad), aliphatic amidase (amiE), L-asparaginase II, (ansB), and hydrogenase accessory protein (hypA), trended to no change or toward repression in the presence of increasing acidity without statistical significance.
FOF1-ATPase
These genes represent the mitochondrial complex responsible for either ATP synthesis or proton export as a function of ATP hydrolysis. In general, the genes that encode for the FOF1-ATPase were induced at pH 6.0, 4.5 and 3.0 when compared to pH 7.4 (Table 3). The F1 epsilon subunit was induced at pH 6.0 and 4.5 when compared to pH 7.4 arguing for increased expression of the ATP synthase and a decline in ATPase activity (28). This subunit inhibits the ATPase activity of the FOF1-ATPase complex, leaving the ATP synthase activity intact (29). Transcription of the gene encoding the pore forming B-subunit was induced at pH 3.0 while transcription of the B′-subunit was not affected by acid. Transcription of the A and C subunits was induced at all acidic pHs studied when compared to pH 7.4 (Table 3). There are at least two possible explanations for the increased transcription of several of the genes encoding the FOF1-ATPase in H. pylori in acid; acid exposure either increases the metabolic demands of the bacterium requiring increased ATP synthesis or reverses the pump to extrude protons to maintain cytoplasmic pH homeostasis at the expense of ATP. To distinguish between these two possibilities, cytoplasmic pH was monitored with the pH-sensitive fluorescent probe BCECF in the presence or absence of the FOF1-ATPase inhibitor DCCD. DCCD addition did not alter cytoplasmic pH, showing that the FOF1-ATPase does not reverse to expel protons from the cytoplasm during an acid challenge. DCCD is bactericidal at pHs > 6.0 but not below (30). The pHin of H. pylori at pHout 6.0 and 7.4 is ~7.8, resulting in an inward pH gradient with the FOF1-ATPase acting as an ATP synthase, not an ATPase. As the pH of the medium is raised, the FOF1-ATPase is required to allow proton entry to maintain a viable internal pH. Therefore, inhibition of the FO subunit by DCCD prevents proton entry, resulting in excessive alkalization and bacterial death. Thus, the FOF1-ATPase does not act as a proton exporting ATPase at high medium pH but as an ATP synthase (Figure 4A). In contrast, antimycin A inhibition of the cytochrome bc1 complex activity resulted in a rapid decline in cytoplasmic pH due to loss of electron transfer and subsequent loss of proton translocation to the periplasm (Figure 4B). Therefore, the electron transport chain is mainly responsible for proton extrusion in acid, not the FOF1-ATPase. These results are in accord with previous data that found no loss of survival after a one hour acid challenge with pump inhibition by DCCD and is also consistent with the increase in the epsilon subunit that inhibits the FOF1-ATPase, sparing the ATP synthase activity of the complex (29–31). Thus, when H. pylori is exposed to an acidic medium pH, the FOF1-ATPase acts as an ATP synthase, not an ATPase. This is presumably due to the requirement for ATP for a variety of reactions in the organism that are not supplied by substrate metabolism and emphasizes the need for acid entry at high medium pH to allow survival. These data are substantiated by the high level of induction of the epsilon subunit that inhibits the ATPase activity of the FOF1-ATPase {Keis, 2006 #194} in the RNA-seq data (Table 3) that show a consistent induction of the FOF1-ATPase genes across the pH range from 6.0 to 3.0.
Figure 4. The FOF1-ATPase does not reverse to translocate protons from the cytoplasm to the extracellular space to maintain internal pH in acid.
(A.) Addition of the FOF1-ATPase inhibitor DCCD did not change cytoplasmic pH in acidic medium. (B.) In contrast, antimycin A inhibition of the cytochrome bc1 complex activity resulted in a rapid decline in cytoplasmic pH due to loss of electron transfer and subsequent loss of proton translocation to the periplasm.
Metabolism
The H. pylori genome encodes for proteins that constitute the major metabolic pathways that include the TCA cycle, the Entner-Doudoroff pathway, the glycolytic pathway and the pentose phosphate pathway (24). Early on, there was controversy as to whether Helicobacter pylori had a complete or modified oxidative citric acid cycle because malate dehydrogenase, malate synthase and α-ketoglutarate open reading frames (ORFs) were not identified in genomic sequence of H. pylori (24). However, biochemical studies detected activity of these three enzymes, suggesting that H. pylori does indeed have a complete citric acid cycle (32). Many of the genes that comprise the TCA pathway were induced at pH 6.0 as compared to pH to pH 7.4 with the exception of ferredoxin, which was repressed by >2-fold (Table 3). Citrate synthase (gltA), located in the cytoplasm, catalyzes the reaction: Acetyl-CoA + H2O + oxaloacetate = citrate + CoA, the first step of the TCA pathway that synthesizes citrate from oxaloacetate. Citrate synthase was induced by nearly 3-fold at pH 6.0, ~2 fold at pH 4.5 and was not induced at pH 3.0. acnB, the gene that encodes for aconitase B, the enzyme that catalyzes the reversible isomerization of citrate to isocitrate via cis-aconitate, was not induced at pH 6.0 or pH 4.5 but was repressed at pH 3.0, showing the same pattern of expression as gltA, namely pH 6.0 > pH 4.5 > pH 3.0. This pattern of decreasing induction or increasing repression with increasing acidity (pH 6.0> pH 4.5 > pH 3.0) is exemplified by many of the genes encoding for metabolic enzymes across all pathways. The only exception to this expression pattern in the TCA pathway is the expression of the OorD subunit of the 2-oxoglutarate oxidoreductase (oorD), whose expression pattern is pH 3.0 > pH 4.5 >pH 6.0. 2-Oxoglutarate oxidoreductase (OOR) of H. pylori is a heterotetramer consisting of four subunits, OorA, OorB, OorC and OorD, with their genes arranged in the order 5′-oorD-oorA-oorB-oorC-3′ (33). Induced expression of oorA and oorB at pH 6.0 with no change in expression at pH 4.5 or 3.0 is indicative of the ATR that induces expression of genes at mild acidity, which is required to combat subsequent high acidity. It is expected that increased metabolism is required to energize the various acid resistant mechanisms expressed by H. pylori.
The expression of genes encoding for the enzymes of the Entner-Doudoroff pathway, glucose-6-phosphate 1-dehydrogenase (zwf, g6pD), phosphogluconate dehydratase (edd) and 2-keto-3-deoxy-6-phosphogluconate aldolase (eda) displayed the same expression pattern as many of the genes of the TCA cycle, pH 6.0 > pH 4.5 > 3.0. This expression pattern suggests the Entner-Douderoff pathway is part of the ATR.
The expression pattern of genes of the glycolytic pathway decreased induction or increased repression with increasing acidity with the exception of phosphoglycerate kinase (pgk), which was nearly equally induced at pH 6.0, 4.5 and 3.0. Phosphoglycerate kinase catalyzes the reaction: ATP + 3-phospho-D-glycerate = ADP + 3-phospho-D-glyceroyl phosphate as step 2 of the pathway that synthesizes pyruvate from D-glyceraldehyde 3-phosphate. It is interesting that the genes encoding for the enzymes for steps 3 and 4 of the pathway, 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (pgm) and enolase (eno), respectively, were repressed when acid challenged. At pH 3.0 most of the genes of the glycolytic pathway were either repressed or did not change expression, suggesting that glycolysis is reduced or inhibited at high acidity and therefore not needed as an energy source for acid resistance. At pH 6.0 about half of the genes of the glycolytic pathway were repressed or unchanged, indicating that it is unlikely glycolysis is part of the ATR. However, gluP, encoding the glucose/galactose transporter, was induced > six-fold at pH 6.0, perhaps in response to the absence or low abundance of medium glucose.
Only genes encoding for the non-oxidative phase of the pentose phosphate pathway changed expression in acid. rpe and tktA, the genes encoding for the enzymes ribulose-phosphate 3-epimerase and transketolase, respectively were repressed with the expression pattern of increasing repression with increasing acidity. tal, the gene encoding for transaldolase was induced in acid.
The pattern of expression of many genes encoding for the various metabolic pathways, namely induction, was greater at pH 6.0 than pH 4.5 and pH 3.0. This expression pattern suggests that mild acidity (pH 6.0) induces the acid tolerance response in H. pylori by preparing the organism to resist stronger acidity and by meeting increased metabolic demand imposed by acid resistance mechanisms.
Antioxidant genes
H. pylori colonization of the stomach results in a robust ROS burst from inflammatory cells in the gastric mucosa to facilitate clearance of the bacterium. In response to ROS generation, H. pylori expresses at least 14 antioxidant proteins to combat ROS degradation of proteins and DNA (24). In addition, H. pylori also expresses DNA and protein repair enzymes to counter ROS induced damage but these are not discussed further, since they are not antioxidants per se. The mechanism of regulation of expression of the antioxidant genes is unknown.
All eight genes encoding for antioxidant proteins that attained statistical significance were induced at pH 6.0 as compared to pH 7.4 (Table 3.). As acidity increased (pH 4.5 and 3.0), the level of induction decreased. katA, the gene encoding for the enzyme catalase, was induced greater than 4-fold at pH 6.0 and greater than 2-fold at pH 4.5 and 3.0. It was also one of the most highly expressed genes in the genome, reflecting that it constitutes nearly 1.5% of total cellular protein (34) and catalyzes the reaction 2H2O2 → 2H2O + O2. Catalase is localized to both the periplasm and cytoplasm (35). Transcription of the gene encoding the peroxiredoxin, alkylhydroperoxide reductase (ahpC) was neither induced nor repressed by an acid challenge. However, in one study, AhpC protein expression decreased in response to oxidative stress (36), while more recently it was shown to increase by 2-fold under oxidative stress conditions (37). This enzyme reduces a variety of peroxides at the same rate and can also inactivate peroxynitrite (38). The generation of peroxynitirite is hindered by the bacterial expression of arginase, removing the source of the nitrite in the host. Superoxide dismutase (sodB) gene expression was induced nearly five-fold with a mild acid challenge (pH 6.0) and 3-fold with greater acidity (pH 4.5 and 3.0). H. pylori/AGS cell co-culture gene expression analysis found that sodB gene transcription was down-regulated with attachment to host cells, suggesting that SOD is important for initial infection but not for persistence (39). This enzyme catalyzes the reaction 2O + 2H+ → H2O2 + O2 and the resulting peroxide is inactivated by catalase. Thus, the enzymes SOD and catalase work in concert to counteract ROS.
H. pylori also expresses thioredoxin reductase (TrxR) and 2 thioredoxins (Trx) that also counteract oxidative stress (40). The organism does not express glutathione, making the expression of TrxR and Trx important for oxidative and nitrosative stress resistance (24, 41). Methionine sulfoxide reductase is also important and is Trx and TrxR dependent, reversing methionine oxidation and restoring protein activity (42).
The current study used neither host cells to generate ROS nor added ROS. Therefore, the acid-induced increased transcription of H. pylori genes that encode for antioxidant proteins suggests that increasing acidity is the significant driver for increased expression. Acid-induced transcription of these genes and subsequent protein expression would be advantageous for the bacterium to mount an effective defense against ROS when infecting the gastric mucosa and to maintain persistence. The data here strongly suggest that pH is important in regulation of these genes and that the organism prepares itself for infection with the first appearance of acidic pH of 6.0.
Motility
Motility is essential for infection (43). Over 50 genes have been identified that contribute to H. pylori motility and chemotaxis (44). There are 3 structures that make up the flagellum, a basal body embedded in the inner membrane that determines rotation and chemotaxis, the helical filament and the hook connecting the basal body and the filament itself. In contrast to other bacteria, these genes in H. pylori are not contiguous but are scattered throughout the chromosome. Analysis of the genome shows that there are 3 sigma factors, σ80, σ54 and σ28, that regulate flagellar transcription.
Genes involved in motility and chemotaxis (and their encoded proteins) are classified into 4 groups based on their temporal and spatial expression. Class 1 genes encode many flagellar regulatory proteins such as FlgR (HP0703), FlgS (HP0244), RpoN (σ54, HP0714), FlhA (HP1041), MotA (HP0815) and MotB (HP0816) and some proteins responsible for chemotaxis. The two-component system, FlgRS and the sigma factor, σ54 regulate the expression of the class 2 genes encoding for proteins that constitute the middle structural unit of the flagellar apparatus. In our RNA-seq analysis, the histidine kinase sensor encoded by flgS and its cognate response regulator, flgR, were only induced at pH 6.0. However, the gene encoding σ54 (rpoN) was repressed at pH 6.0 and pH 4.5, as were half of the other class 1 genes (Table 3). The genes encoding the flagellar motor proteins motA and motB were repressed by more than 2-fold at all acidic pHs as compared to pH 7.4. cheA, encoding the chemotactic histidine kinase, was induced with mild acidity (pH 6.0) but was unchanged at pHs 3.0 and 4.5 as compared to pH 7.4 while its cognate phospho-receptor, cheY was at repressed at all acidic pHs tested as compared to pH 7.4. Like cheA, the methyl-accepting chemotaxis protein encoding genes tlpA and tlpB were induced only with mild acidity (pH 6.0) while tlpC was induced only at pH 3.0.
The intermediate class of motility genes includes flgM, which was induced at pH 3.0 (Table 3). This protein is secreted, relieving suppression and allowing synthesis of the class 3 genes. These class 3 genes (Table 3) are regulated by FliA/σ28 and fliA is regulated by FlgM/anti-σ28. Both genes changed in parallel with decreased transcription at pH 6.0 as compared to pH 7.4 and had a 2-fold increase at pH 3.0. The class 3 genes encode for proteins that constitute the late flagellar structure and all increased expression with increasing acidity with the exception of flaA, which failed to reach statistical significance but trended to no change in expression with an acid challenge.
FlaA and FlaB, encoded by the genes, flaA and flaB respectively, comprise the flagellar filament. flaA transcription was unaffected by acidity, while flaB was induced with decreasing pH. Merrell et al found an increase in flaB message at pH 5.0 after 30 minutes exposure but no longer (up to 2 hours) as compared to pH 7.0 but did not detect any changes in the transcription of flaA (11). Wen et al detected increased transcription of flaB and also flaA after a 30 minute acid challenge at pH 4.5, as did Dong et al after a prolonged acid challenge (5 passages) (10, 45). The difference in expression of the flaA and flaB genes may be dependent on the growth phase. The previous acid transcriptome studies were of short duration (30 minutes – 2 hours), with the bacteria more likely to be in lag phase given the slow growth rate of H. pylori. In the current study, the bacteria were acid challenged for 4 hours, likely placing them at least in early growth phase. It has been shown that flaB expression occurs earlier in the growth phase then expression of flaA, thus accounting for the difference in expression of flaA and flaB (46).
The intermediate class of flagellar genes were mostly down-regulated or unchanged when acid challenged for 4 hours. In particular, a number of genes in this class were repressed at pH 6.0. Notable exceptions were fliA, flhF, flgI, and flgM, which were repressed or did not change at pH 6.0 but were induced at pHs 3.0 or 4.5. These genes are regulators of flagellar biosynthesis and their increased transcription suggests an impending increase in flagellar synthesis that perhaps would have been seen more clearly with a more prolonged acid challenge later in the bacterium’s growth cycle. In general, it is clear that motility is positively pH regulated, requiring the cooperation of several genes that are translated in order to correctly assemble the flagellar system, generating the motility essential for infection (43).
Outer Membrane Proteins (OMPs)
Adherence of H. pylori to the gastric epithelium is a necessary step in establishing successful infection because it provides protection from clearance mechanisms such as bulk liquid flow, gastric peristalsis and the continuous shedding and replenishment of the mucus layer. H. pylori has evolved specific virulence determinants on their outer-membrane which recognize distinct protein, proteolipids or carbohydrates expressed on epithelial cells. These virulence factors are adhesins that bind to mucins in the gastric mucus and receptors on the surface of the gastric mucosa.
H. pylori expresses about 64 OMPs which can be organized into at least 5 paralogous gene families. Family 1 is composed of the Hop and Hor genes. These genes encode for adhesion proteins and include the well-studied BabA/B/C, SabA/B and AlpA/B. BabA is regulated by phase variation through a slipped strand mechanism (SSM). In the current study, although the babA and babB data failed to reach statistical significance, acid exposure had no effect on babA/B transcription (Table S1).
H. pylori infection of the gastric mucosa results in chronic active gastritis. This inflammation results in the replacement of the naturally produced Lewis antigens and the expression of sialylated glycans such as sialyl-Lea and sialyl Lex (47). In the absence of BabA, an adhesin was identified that binds to sialyl Lex antigen and named SabA (48). As with babA, sabA expression is regulated by SSM and was also shown to be inversely related to gastric acidity (49). The acid transcriptomes performed by Merrell et al and Bury-Mone et al also found repression of both the sabA and sabB genes in acid. These results are in contrast with the results of the current RNAseq study, which found that the sabA and sabB genes were highly induced by acid exposure, 10 and 4-fold, respectively (Table 3). The differences in the experimental conditions used among the various studies may explain the discrepancies in the results. The Merrell et al and Bury-Mone et al acid transcriptomes were made in the absence of urea and both groups did not control for changes in medium pH due to bacterial metabolism and urease activity. In the current study both these parameters were controlled for, suggesting that the presence of urea may induce sabA and sabB expression in acid. Hence, acid and urea may act as a signal to the bacterium that it is in the gastric environment and now requires robust expression of adhesins to maintain infection. There is evidence that sabA is a member of the ArsRS acid responsive regulon (22). Gene expression of SabA wild-type H. pylori and an isogenic ArsS histidine kinase mutant, found sabA was derepressed in the mutant (50). Since the ArsRS two component system negatively autoregulates, it is not surprising that sabA gene expression is induced in acid. Additionally, it was shown that ArsR binds to the sabA and sabB promoters, more evidence that their expression is acid induced (51).
H. pylori isogenic mutants lacking the OMP HopZ failed to adhere to the gastric carcinoma derived AGS cells (52), indicating that it is an adhesion, but its receptor is unknown. Like sabA, hopZ expression is regulated by SSM, however, in this study, transcription was acid induced. The acid transcriptome analysis of Merrell et al indicated that acid repressed transcription of hopZ. Two other OMPs, AlpA and AlpB, have been identified as putative adhesins due to loss of binding to gastric epithelium of their respective isogenic mutants (53) and, as with HopZ, the host receptors have not been identified. Like the adhesins discussed above, alpA and alpB were repressed in the acid transcriptome study by Merrell et al and induced in acid in this study.
The OMP family 2 genes encode for OMPSs of unknown function. hofA and hofE were repressed in acid, while hofB was induced. Previous transcriptome studies found no change of expression of these genes. The only member of the OMP family 3 genes that changed expression in acid was homA. In this study, homA was induced in acid. The acid induction of homA contrasts with the work by Bury-Mone et al that showed acid repression of this gene (12). The difference may be due to the presence of urea in the current study.
The OMP family 5 genes encode for efflux pump proteins. The hefA gene encodes the outer membrane protein of the HefABC efflux system involved in resistance to antibiotics (54). The resistance-nodulation-division (RND) family of efflux systems is widespread among gram-negative bacteria. They are associated with bacterial resistance to antibiotics. hefA, hefD and hefG encode for a homolog of the E. coli TolC protein of the AcrAB-TolC system. In the current study, hefA was induced at pHs 4.5 and 3.0, while hefD and hefG were repressed with mild acidity (pH 6.0).
Several OMPs that are not part of the OMP family categorization changed expression in acid. Among these was HP0726, which was repressed in acid in this study but was induced at pH 4.0 in the absence of urea after 30 minutes incubation (55). HP0785, a periplasmic chaperone involved in membrane biogenesis, was induced in acid. The gene encoding an outer membrane protein, plpA (HP1564), belonging to the lipoprotein-28 superfamily and showing similarity to a Pasteurella haemolytica lipoprotein 1, was induced 3-fold in acid (56). The acid induction of these two OMPs is perhaps to respond to membrane damage or to increase the protective response of the membrane to protons. Recognizing that most OMPs express porins (57), it will be important to identify the transport properties of these porins, with special attention to proton flux and the transport of urea.
Type 4 Secretion System (T4SS)/Cag pathogenicity island (PAI)
The bacterial type IV secretion systems move DNA or protein substrates into other bacteria or into eukaryotes. The T4SS is a nanomachine composed of 4 distinct complexes; (a) the type IV coupling protein, a hexameric ATPase (b) an inner membrane complex transferring substrate across the inner membrane (c) an outer membrane complex transferring substrate across the periplasm and outer membrane and (d) the conjugative pilus that contacts the host cell composed of several different subunits in H. pylori (58). The T4SS regulon of H. pylori G27 strain reflects the pathogenicity island obtained by horizontal transfer of DNA from other organisms and is controlled by 10 promoters (59). In H. pylori, the T4SS is SEC independent and is involved in DNA transfer and injection of CagA, a pathogenic protein, into gastric epithelial cells (60). In our analysis, for about 60% of the genes that comprise the T4SS regulon, transcription was acid induced and generally increased with increasing acidity (Table 9). Exceptions were cag16 (CagM), which is unique to the H. pylori T4SS, and cag26 (CagA), with the former being repressed at pH 6.0 and 4.5 while the latter was repressed at pH 3.0. Three of the genes of the PCagζ operon, cag2 through cag4 (HP0521-HP0523), were acid induced at pH 3.0. The remaining member of this operon, cag1 (HP05200), failed to attain statistical significance. Five of the 6 of the PCagV (cag5, cag6, cag9, cag10 and VirB11) regulated genes were induced at pH 3.0 with cag6 being equally induced at all acidic pHs. cag12, cag13 and cag14 had induced transcription equally at all acid pHs when compared to pH 7.4. The genes regulated by the PCagF promoter, cag19 (CagI, HP0524), cag20 (CagH, HP0541), cag21 (CagG, HP0542) and cag22 (CagF, HP0543), were acid induced at all three acid pHs studied, except for cag19, which failed to attain statistical significance although its transcription trended to be independent of acidity. cag18 (CagL/VirB5, HP0539), also regulated by the PcagF promoter, was acid induced at only pH 3.0. CagL (cag18) is a VirB5 homolog, while all the remaining members are unique to the H. pylori T4SS. CagL is an adhesin on the pilus surface, which binds to the integrin α5β1 receptor on the gastric epithelial surface through an arginine–glycine–aspartate (RGD) motif (61). CagL binding initiates CagA translocation into gastric epithelial cells. Previous in vitro, target cell-free transcriptomal studies found no change in expression of cagL in acid (10, 11). It is possible that target cells are required for robust cagL expression, although transcriptome analyses of in vitro co-culture (39) or in vivo (9) did not detect changes in expression. cag22 encodes for the CagA chaperone CagF (HP0543) (62) and may be the rate limiting step in CagA translocation due to its >50 fold less expression than CagA. Much less is known about the remaining members of the PCagF operon and putative functions of the proteins encoded by these genes is based on protein-protein interactions and cellular localization studies (63, 64). cag23 failed to attain statistical significance at all acid pHs but trended toward increased transcription with increasing acidity. cag24, a member of the PCagC operon, was acid induced equally (2-fold) at all acidic pHs, while cag25 only showed induction at pH 3.0. The proteins encoded by these genes are required for CagA translocation and IL-8 induction. Primer extension analysis of PCagC showed an acid induced increase in transcription levels in accord with the increase seen in the genes of its regulon (65). cag25 encodes for CagC/VirB2 (HP0546) protein localized to the inner and outer membrane, forming the injection pilus (66). Its acid induction argues for a pH dependent formation of the pilus. cag24 encodes CagD (HP0545), a periplasmic localized protein of unknown function unique to the H. pylori T4SS. CagD is secreted, associates with the pilus, and is required for maximum IL-8 secretion (67). cag23 encodes for the VirB3/B4 homolog CagE (HP0544) and is an inner membrane associated NTPase that stabilizes pilus formation and T4SS assembly (68).
In our analysis, many of the genes that comprise the T4SS regulon displayed a transcription pattern of induction that increased with increasing acidity (Table 3). None of the proteins encoded by the genes of the CAG-PAI are necessary for acid survival/protection because CAG negative strains survive an acid challenge just as well as CAG positive strains. We suggest that acidity serves as a signal to the bacterium that it has reached its site of infection, the gastric mucosa, and the induction of the CAG-PAI genes prepares the T4SS for the injection of CagA into the host cells. It is interesting that an acid challenge had no effect on the transcription of CagA, suggesting that its regulation is dependent on H. pylori adherence to host cells or it is constitutively expressed at adequate levels.
Cell Division
The mechanism of bacterial cell division is a series of coordinated steps beginning with chromosome replication and segregation and ending in septation of the organism. Most of the cell division genes that were either induced or repressed in response to an acid challenge were from the fts and min loci. The genes of the min loci determine the division site and recruit ftsZ to the site to establish the Z ring. The min locus is composed of three genes, minC, minD and minE. The proper placement of the septal FtsZ ring is mediated by oscillation of a complex of these proteins and membrane placement of the complex requires all three proteins (69). MinE expression results in redistribution of MinC and D, eventually assembling into a ring like structure at mid-cell (the E ring). The average concentration of the division inhibitor, MinC is lowest in the middle of the cell. MinC deletion mutants form filamentous long cells but form short rods when complemented by wild type MinC (70). Here, all three genes were upregulated at pH 3.0. MinE, in particular, increased expression at pH 3.0 but declined at pH 6.0. In E. coli, the MinC and MinD proteins form a complex that inhibits cell division while MinE stimulates cell division. Competition between MinCD and MinE determines the rate of cell division (71).
Genes of the fts locus are involved in septum formation. After formation of the Z-ring, FtsZ recruits FtsA to the septum, and it is the FtsA and FtsZ ratio that determines initiation of cell division, with FtsA inhibiting cell division and FtsZ stimulating cell division. Transcription of ftsA was acid induced while ftsZ was acid repressed, indicating inhibition of cell division. E. coli regulates the expression of the ftsA and ftsZ genes via the two-component system, ResCB (72). Since H. pylori has only four complete TCSs of which two, ArsRS and FlgSR, sense and respond to acidity, it is tempting to speculate that the ftsA and ftsZ genes, in responding to acidity, are regulated through one of these acid sensing TCSs (26, 73).
Acid exposure repressed the transcription of three other genes in the fts locus, ftsH, ftsK and ftsX. ftsH is represented by two genes in the H. pylori genome, HP0286 and Hp1069, which is essential for cell division (74). Repression of HP0286 suggests that the bacterium is in a non-dividing state. On the other hand, HP1069 was induced in acid. In E. coli, ftsH encodes for an ATP-dependent zinc protease that has been shown to degrade SecY, the Fo subunit, sigma 32 and EnvA (75, 76). Given that the two ftsH genes respond reciprocally to acid exposure, it is possible to speculate that the role of HP1069 is regulation of cell division while the role of HP0286 is mainly as a protease but is also involved with disassembling the septum. ftsK and xerC may be involved in the dimerization of the nascent chromosome and both were repressed when acid challenged (77).
The cell division acid transcriptome indicates that under the conditions used in this study, the bacterium is in a non-dividing state but poised to replicate, as evidenced by repression of most of the fts genes and induction of the min genes.
Conclusion
H. pylori has had to develop a unique response to acidity to facilitate acid acclimation and persistent gastric habitation. This response requires an ability to sense changes in environmental/periplasmic and cytoplasmic pH, and initiate a rapid and sustained change in transcription of relevant genes. Genes involved with acid acclimation, motility, FOF1-ATPase, reactive oxygen species, and T4SS/Cag pathogenicity island all showed increased expression at acidic pH, with some genes increasing more significantly at different extremes of acidity. Measurement of internal pH confirmed that, despite tight regulation by the bacteria, they do see some degree of pH change in response to external acidity, and even mild acidity can trigger important transcriptional alterations. As indicated by qPCR over several time points, many of these changes are more pronounced with longer time of exposure to acidic pH, consistent with the need for H. pylori to colonize the stomach rather than simply transit it on the way to less harsh environments in the more distal GI tract. The ability of H. pylori to sense acidity is critical not only to trigger acid acclimation, but also to stimulate transcription of virulence factors needed for colonization. Exposure to acid and urea are critical for all facets of gastric survival. With the current challenges in treating H. pylori infection and the worldwide disease burden, it is important to focus on development of non-antibiotic treatment targets for eradication of infection. The first step in this process is understanding how the bacteria can colonize their host. H. pylori relies on a wide range of transcriptional changes across different functional groups of genes to allow for persistence in the harsh gastric environment. Alteration of or interference with any of these adaptive responses, or with the ability to sense environmental pH, present attractive targets for eradication of infection.
Supplementary Material
Acknowledgments
Funding information: Supported by K08DK100661 (EAM), R03DK110579 (EAM), UCLA Children’s Discovery and Innovation Institute and Today’s and Tomorrow’s Children Fund (EAM), USVA 2I01BX001006 (GS), 1R01DK105156-01 (GS).
Abbreviations
- BCA
bicinchoninic acid
- BHI
brain heart infusion
- SDS-PAGE
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
- TCS
two component system
- TSA
Trypticase Soy Agar
- pmf
proton motive force
- DCCD
N, N′-dicyclohexylcarbodiimide
- BCECF-AM
2,7-bis-(2-carboxyethyl)-5-carboxyfluorescein acetoxymethyl ester
- PPI
proton pump inhibitor
- ROS
reactive oxygen species
- YE
yeast extract
References
- 1.Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002 Oct 10;347(15):1175–86. doi: 10.1056/NEJMra020542. [DOI] [PubMed] [Google Scholar]
- 2.Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991 Oct 17;325(16):1127–31. doi: 10.1056/NEJM199110173251603. [DOI] [PubMed] [Google Scholar]
- 3.Parsonnet J. Gastric adenocarcinoma and Helicobacter pylori infection. West J Med. 1994 Jul;161(1):60. [PMC free article] [PubMed] [Google Scholar]
- 4.Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991 Oct 17;325(16):1132–6. doi: 10.1056/NEJM199110173251604. [DOI] [PubMed] [Google Scholar]
- 5.Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology. 1992 Feb;102(2):720–7. doi: 10.1016/0016-5085(92)90126-j. [DOI] [PubMed] [Google Scholar]
- 6.Lehours P, Yilmaz O. Epidemiology of Helicobacter pylori infection. Helicobacter. 2007 Oct;12(Suppl 1):1–3. doi: 10.1111/j.1523-5378.2007.00541.x. [DOI] [PubMed] [Google Scholar]
- 7.Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984 Jun 16;1(8390):1311–5. doi: 10.1016/s0140-6736(84)91816-6. [DOI] [PubMed] [Google Scholar]
- 8.Schade C, Flemstrom G, Holm L. Hydrogen ion concentration in the mucus layer on top of acid-stimulated and -inhibited rat gastric mucosa. Gastroenterology. 1994 Jul;107(1):180–8. doi: 10.1016/0016-5085(94)90075-2. [DOI] [PubMed] [Google Scholar]
- 9.Scott DR, Marcus EA, Wen Y, Oh J, Sachs G. Gene expression in vivo shows that Helicobacter pylori colonizes an acidic niche on the gastric surface. Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7235–40. doi: 10.1073/pnas.0702300104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Wen Y, Marcus EA, Matrubutham U, Gleeson MA, Scott DR, Sachs G. Acid-adaptive genes of Helicobacter pylori. Infect Immun. 2003 Oct;71(10):5921–39. doi: 10.1128/IAI.71.10.5921-5939.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Merrell DS, Goodrich ML, Otto G, Tompkins LS, Falkow S. pH-regulated gene expression of the gastric pathogen Helicobacter pylori. Infect Immun. 2003 Jun;71(6):3529–39. doi: 10.1128/IAI.71.6.3529-3539.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Bury-Mone S, Thiberge JM, Contreras M, Maitournam A, Labigne A, De Reuse H. Responsiveness to acidity via metal ion regulators mediates virulence in the gastric pathogen Helicobacter pylori. Mol Microbiol. 2004 Jul;53(2):623–38. doi: 10.1111/j.1365-2958.2004.04137.x. [DOI] [PubMed] [Google Scholar]
- 13.Ang S, Lee CZ, Peck K, Sindici M, Matrubutham U, Gleeson MA, et al. Acid-induced gene expression in Helicobacter pylori: study in genomic scale by microarray. Infect Immun. 2001 Mar;69(3):1679–86. doi: 10.1128/IAI.69.3.1679-1686.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5791–5. doi: 10.1073/pnas.90.12.5791. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Baltrus DA, Amieva MR, Covacci A, Lowe TM, Merrell DS, Ottemann KM, et al. The complete genome sequence of Helicobacter pylori strain G27. J Bacteriol. 2009 Jan;191(1):447–8. doi: 10.1128/JB.01416-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, et al. Primer3--new capabilities and interfaces. Nucleic Acids Res. 2012 Aug;40(15):e115. doi: 10.1093/nar/gks596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Koressaar T, Remm M. Enhancements and modifications of primer design program Primer3. Bioinformatics. 2007 May 15;23(10):1289–91. doi: 10.1093/bioinformatics/btm091. [DOI] [PubMed] [Google Scholar]
- 18.Scott DR, Marcus EA, Weeks DL, Lee A, Melchers K, Sachs G. Expression of the Helicobacter pylori ureI gene is required for acidic pH activation of cytoplasmic urease. Infect Immun. 2000 Feb;68(2):470–7. doi: 10.1128/iai.68.2.470-477.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Sachs G, Weeks DL, Melchers K, Scott DR. The gastric biology of Helicobacter pylori. Annu Rev Physiol. 2003;65:349–69. doi: 10.1146/annurev.physiol.65.092101.142156. [DOI] [PubMed] [Google Scholar]
- 20.Marcus EA, Moshfegh AP, Sachs G, Scott DR. The periplasmic alpha-carbonic anhydrase activity of Helicobacter pylori is essential for acid acclimation. J Bacteriol. 2005 Jan;187(2):729–38. doi: 10.1128/JB.187.2.729-738.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Meyer-Rosberg K, Scott DR, Rex D, Melchers K, Sachs G. The effect of environmental pH on the proton motive force of Helicobacter pylori. Gastroenterology. 1996 Oct;111(4):886–900. doi: 10.1016/s0016-5085(96)70056-2. [DOI] [PubMed] [Google Scholar]
- 22.Pflock M, Finsterer N, Joseph B, Mollenkopf H, Meyer TF, Beier D. Characterization of the ArsRS regulon of Helicobacter pylori, involved in acid adaptation. J Bacteriol. 2006 May;188(10):3449–62. doi: 10.1128/JB.188.10.3449-3462.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Akada JK, Shirai M, Takeuchi H, Tsuda M, Nakazawa T. Identification of the urease operon in Helicobacter pylori and its control by mRNA decay in response to pH. Mol Microbiol. 2000 Jun;36(5):1071–84. doi: 10.1046/j.1365-2958.2000.01918.x. [DOI] [PubMed] [Google Scholar]
- 24.Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997 Aug 7;388(6642):539–47. doi: 10.1038/41483. [DOI] [PubMed] [Google Scholar]
- 25.Muller S, Gotz M, Beier D. Histidine residue 94 is involved in pH sensing by histidine kinase ArsS of Helicobacter pylori. PLoS One. 2009 Sep 7;4(9):e6930. doi: 10.1371/journal.pone.0006930. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Wen Y, Feng J, Scott DR, Marcus EA, Sachs G. The pH-responsive regulon of HP0244 (FlgS), the cytoplasmic histidine kinase of Helicobacter pylori. J Bacteriol. 2009 Jan;191(2):449–60. doi: 10.1128/JB.01219-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.McGee DJ, Radcliff FJ, Mendz GL, Ferrero RL, Mobley HL. Helicobacter pylori rocF is required for arginase activity and acid protection in vitro but is not essential for colonization of mice or for urease activity. J Bacteriol. 1999 Dec;181(23):7314–22. doi: 10.1128/jb.181.23.7314-7322.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Sun Y, Fukamachi T, Saito H, Kobayashi H. ATP requirement for acidic resistance in Escherichia coli. J Bacteriol. 2011 Jun;193(12):3072–7. doi: 10.1128/JB.00091-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Futai M, Noumi T, Maeda M. Mechanism of F1-ATPase studied by the genetic approach. J Bioenerg Biomembr. 1988 Aug;20(4):469–80. doi: 10.1007/BF00762204. [DOI] [PubMed] [Google Scholar]
- 30.McGowan CC, Cover TL, Blaser MJ. Analysis of F1F0-ATPase from Helicobacter pylori. Infect Immun. 1997 Jul;65(7):2640–7. doi: 10.1128/iai.65.7.2640-2647.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Keis S, Stocker A, Dimroth P, Cook GM. Inhibition of ATP hydrolysis by thermoalkaliphilic F1Fo-ATP synthase is controlled by the C terminus of the epsilon subunit. J Bacteriol. 2006 Jun;188(11):3796–804. doi: 10.1128/JB.00040-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Hoffman PS, Goodwin A, Johnsen J, Magee K, Veldhuyzen van Zanten SJ. Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance. J Bacteriol. 1996 Aug;178(16):4822–9. doi: 10.1128/jb.178.16.4822-4829.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Hughes NJ, Clayton CL, Chalk PA, Kelly DJ. Helicobacter pylori porCDAB and oorDABC genes encode distinct pyruvate:flavodoxin and 2- oxoglutarate:acceptor oxidoreductases which mediate electron transport to NADP. J Bacteriol. 1998 Mar;180(5):1119–28. doi: 10.1128/jb.180.5.1119-1128.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Bauerfeind P, Garner R, Dunn BE, Mobley HL. Synthesis and activity of Helicobacter pylori urease and catalase at low pH. Gut. 1997 Jan;40(1):25–30. doi: 10.1136/gut.40.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Harris AG, Hazell SL. Localisation of Helicobacter pylori catalase in both the periplasm and cytoplasm, and its dependence on the twin-arginine target protein, KapA, for activity. FEMS Microbiol Lett. 2003 Dec 12;229(2):283–9. doi: 10.1016/S0378-1097(03)00850-4. [DOI] [PubMed] [Google Scholar]
- 36.Chuang MH, Wu MS, Lin JT, Chiou SH. Proteomic analysis of proteins expressed by Helicobacter pylori under oxidative stress. Proteomics. 2005 Oct;5(15):3895–901. doi: 10.1002/pmic.200401232. [DOI] [PubMed] [Google Scholar]
- 37.Huang CH, Chiou SH. Proteomic analysis of upregulated proteins in Helicobacter pylori under oxidative stress induced by hydrogen peroxide. Kaohsiung J Med Sci. 2011 Dec;27(12):544–53. doi: 10.1016/j.kjms.2011.06.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Barnard FM, Loughlin MF, Fainberg HP, Messenger MP, Ussery DW, Williams P, et al. Global regulation of virulence and the stress response by CsrA in the highly adapted human gastric pathogen Helicobacter pylori. Mol Microbiol. 2004 Jan;51(1):15–32. doi: 10.1046/j.1365-2958.2003.03788.x. [DOI] [PubMed] [Google Scholar]
- 39.Kim N, Marcus EA, Wen Y, Weeks DL, Scott DR, Jung HC, et al. Genes of Helicobacter pylori regulated by attachment to AGS cells. Infect Immun. 2004 Apr;72(4):2358–68. doi: 10.1128/IAI.72.4.2358-2368.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Windle HJ, Fox A, Ni Eidhin D, Kelleher D. The thioredoxin system of Helicobacter pylori. J Biol Chem. 2000 Feb 18;275(7):5081–9. doi: 10.1074/jbc.275.7.5081. [DOI] [PubMed] [Google Scholar]
- 41.Gobert AP, Wilson KT. The Immune Battle against Helicobacter pylori Infection: NO Offense. Trends Microbiol. 2016 May;24(5):366–76. doi: 10.1016/j.tim.2016.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Benoit SL, Bayyareddy K, Mahawar M, Sharp JS, Maier RJ. Alkyl hydroperoxide reductase repair by Helicobacter pylori methionine sulfoxide reductase. J Bacteriol. 2013 Dec;195(23):5396–401. doi: 10.1128/JB.01001-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Ottemann KM, Lowenthal AC. Helicobacter pylori uses motility for initial colonization and to attain robust infection. Infect Immun. 2002 Apr;70(4):1984–90. doi: 10.1128/IAI.70.4.1984-1990.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Lertsethtakarn P, Ottemann KM, Hendrixson DR. Motility and chemotaxis in Campylobacter and Helicobacter. Annu Rev Microbiol. 2011;65:389–410. doi: 10.1146/annurev-micro-090110-102908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Dong Q, Hyde D, Herra C, Kean C, Murphy P, O’Morain CA, et al. Identification of genes regulated by prolonged acid exposure in Helicobacter pylori. FEMS Microbiol Lett. 2001 Mar 15;196(2):245–9. doi: 10.1111/j.1574-6968.2001.tb10572.x. [DOI] [PubMed] [Google Scholar]
- 46.Merrell DS, Thompson LJ, Kim CC, Mitchell H, Tompkins LS, Lee A, et al. Growth phase-dependent response of Helicobacter pylori to iron starvation. Infect Immun. 2003 Nov;71(11):6510–25. doi: 10.1128/IAI.71.11.6510-6525.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Magalhaes A, Marcos-Pinto R, Nairn AV, Dela Rosa M, Ferreira RM, Junqueira-Neto S, et al. Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways. Biochim Biophys Acta. 2015 Sep;1852(9):1928–39. doi: 10.1016/j.bbadis.2015.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Aspholm M, Olfat FO, Norden J, Sonden B, Lundberg C, Sjostrom R, et al. SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog. 2006 Oct;2(10):e110. doi: 10.1371/journal.ppat.0020110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Yamaoka Y, Ojo O, Fujimoto S, Odenbreit S, Haas R, Gutierrez O, et al. Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut. 2006 Jun;55(6):775–81. doi: 10.1136/gut.2005.083014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Goodwin AC, Weinberger DM, Ford CB, Nelson JC, Snider JD, Hall JD, et al. Expression of the Helicobacter pylori adhesin SabA is controlled via phase variation and the ArsRS signal transduction system. Microbiology. 2008 Aug;154(Pt 8):2231–40. doi: 10.1099/mic.0.2007/016055-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Acio-Pizzarello CR, Acio AA, Choi EJ, Bond K, Kim J, Kenan AC, et al. Determinants of the regulation of Helicobacter pylori adhesins include repeat sequences in both promoter and coding regions as well as the two-component system ArsRS. J Med Microbiol. 2017 Jun;66(6):798–807. doi: 10.1099/jmm.0.000491. [DOI] [PubMed] [Google Scholar]
- 52.Peck B, Ortkamp M, Diehl KD, Hundt E, Knapp B. Conservation, localization and expression of HopZ, a protein involved in adhesion of Helicobacter pylori. Nucleic Acids Res. 1999 Aug 15;27(16):3325–33. doi: 10.1093/nar/27.16.3325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Odenbreit S, Faller G, Haas R. Role of the alpAB proteins and lipopolysaccharide in adhesion of Helicobacter pylori to human gastric tissue. Int J Med Microbiol. 2002 Sep;292(3–4):247–56. doi: 10.1078/1438-4221-00204. [DOI] [PubMed] [Google Scholar]
- 54.Bina JE, Alm RA, Uria-Nickelsen M, Thomas SR, Trust TJ, Hancock RE. Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro. Antimicrob Agents Chemother. 2000 Feb;44(2):248–54. doi: 10.1128/aac.44.2.248-254.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.McGowan CC, Necheva AS, Forsyth MH, Cover TL, Blaser MJ. Promoter analysis of Helicobacter pylori genes with enhanced expression at low pH. Mol Microbiol. 2003 Jun;48(5):1225–39. doi: 10.1046/j.1365-2958.2003.03500.x. [DOI] [PubMed] [Google Scholar]
- 56.Utt M, Nilsson I, Ljungh A, Wadstrom T. Identification of novel immunogenic proteins of Helicobacter pylori by proteome technology. J Immunol Methods. 2002 Jan 1;259(1–2):1–10. doi: 10.1016/s0022-1759(01)00476-8. [DOI] [PubMed] [Google Scholar]
- 57.Doig P, Exner MM, Hancock RE, Trust TJ. Isolation and characterization of a conserved porin protein from Helicobacter pylori. J Bacteriol. 1995 Oct;177(19):5447–52. doi: 10.1128/jb.177.19.5447-5452.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Christie PJ, Whitaker N, Gonzalez-Rivera C. Mechanism and structure of the bacterial type IV secretion systems. Biochim Biophys Acta. 2014 Aug;1843(8):1578–91. doi: 10.1016/j.bbamcr.2013.12.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Vannini A, Roncarati D, Spinsanti M, Scarlato V, Danielli A. In depth analysis of the Helicobacter pylori cag pathogenicity island transcriptional responses. PLoS One. 2014;9(6):e98416. doi: 10.1371/journal.pone.0098416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Tegtmeyer N, Wessler S, Backert S. Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J. 2011 Apr;278(8):1190–202. doi: 10.1111/j.1742-4658.2011.08035.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Kwok T, Zabler D, Urman S, Rohde M, Hartig R, Wessler S, et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature. 2007 Oct 18;449(7164):862–6. doi: 10.1038/nature06187. [DOI] [PubMed] [Google Scholar]
- 62.Pattis I, Weiss E, Laugks R, Haas R, Fischer W. The Helicobacter pylori CagF protein is a type IV secretion chaperone-like molecule that binds close to the C-terminal secretion signal of the CagA effector protein. Microbiology. 2007 Sep;153(Pt 9):2896–909. doi: 10.1099/mic.0.2007/007385-0. [DOI] [PubMed] [Google Scholar]
- 63.Busler VJ, Torres VJ, McClain MS, Tirado O, Friedman DB, Cover TL. Protein-protein interactions among Helicobacter pylori cag proteins. J Bacteriol. 2006 Jul;188(13):4787–800. doi: 10.1128/JB.00066-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Fischer W, Puls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol. 2001 Dec;42(5):1337–48. doi: 10.1046/j.1365-2958.2001.02714.x. [DOI] [PubMed] [Google Scholar]
- 65.Cendron L, Zanotti G. Structural and functional aspects of unique type IV secretory components in the Helicobacter pylori cag-pathogenicity island. FEBS J. 2011 Apr;278(8):1223–31. doi: 10.1111/j.1742-4658.2011.08038.x. [DOI] [PubMed] [Google Scholar]
- 66.Andrzejewska J, Lee SK, Olbermann P, Lotzing N, Katzowitsch E, Linz B, et al. Characterization of the pilin ortholog of the Helicobacter pylori type IV cag pathogenicity apparatus, a surface-associated protein expressed during infection. J Bacteriol. 2006 Aug;188(16):5865–77. doi: 10.1128/JB.00060-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Cendron L, Couturier M, Angelini A, Barison N, Stein M, Zanotti G. The Helicobacter pylori CagD (HP0545, Cag24) protein is essential for CagA translocation and maximal induction of interleukin-8 secretion. J Mol Biol. 2009 Feb 13;386(1):204–17. doi: 10.1016/j.jmb.2008.12.018. [DOI] [PubMed] [Google Scholar]
- 68.Shariq M, Kumar N, Kumari R, Kumar A, Subbarao N, Mukhopadhyay G. Biochemical Analysis of CagE: A VirB4 Homologue of Helicobacter pylori Cag-T4SS. PLoS One. 2015;10(11):e0142606. doi: 10.1371/journal.pone.0142606. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Kang GB, Song HE, Kim MK, Youn HS, Lee JG, An JY, et al. Crystal structure of Helicobacter pylori MinE, a cell division topological specificity factor. Mol Microbiol. 2010 Jun 1;76(5):1222–31. doi: 10.1111/j.1365-2958.2010.07160.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Chiou PY, Luo CH, Chang KC, Lin NT. Maintenance of the cell morphology by MinC in Helicobacter pylori. PLoS One. 2013;8(8):e71208. doi: 10.1371/journal.pone.0071208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Sullivan SM, Maddock JR. Bacterial division: Finding the dividing line. Curr Biol. 2000 Mar 23;10(6):R249–52. doi: 10.1016/s0960-9822(00)00376-6. [DOI] [PubMed] [Google Scholar]
- 72.Carballes F, Bertrand C, Bouche JP, Cam K. Regulation of Escherichia coli cell division genes ftsA and ftsZ by the two-component system rcsC-rcsB. Mol Microbiol. 1999 Nov;34(3):442–50. doi: 10.1046/j.1365-2958.1999.01605.x. [DOI] [PubMed] [Google Scholar]
- 73.Beier D, Frank R. Molecular characterization of two-component systems of Helicobacter pylori. J Bacteriol. 2000 Apr;182(8):2068–76. doi: 10.1128/jb.182.8.2068-2076.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Gupta RS. Molecular signatures (unique proteins and conserved indels) that are specific for the epsilon proteobacteria (Campylobacterales) BMC Genomics. 2006 Jul 4;7:167. doi: 10.1186/1471-2164-7-167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Chiba S, Akiyama Y, Ito K. Membrane protein degradation by FtsH can be initiated from either end. J Bacteriol. 2002 Sep;184(17):4775–82. doi: 10.1128/JB.184.17.4775-4782.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Kihara A, Akiyama Y, Ito K. FtsH is required for proteolytic elimination of uncomplexed forms of SecY, an essential protein translocase subunit. Proc Natl Acad Sci U S A. 1995 May 9;92(10):4532–6. doi: 10.1073/pnas.92.10.4532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Aussel L, Barre FX, Aroyo M, Stasiak A, Stasiak AZ, Sherratt D. FtsK Is a DNA motor protein that activates chromosome dimer resolution by switching the catalytic state of the XerC and XerD recombinases. Cell. 2002 Jan 25;108(2):195–205. doi: 10.1016/s0092-8674(02)00624-4. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.




